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Capacitive bioaffinity detection using microelectrodes is considered as a 
promising label-free method for point-of-care diagnosis, though with challenges 
in sensitivity, specificity and the time “from sample to result.” This work presents 
an alternating current (AC)-electrokinetic based capacitive affinity sensing 
method that is capable of realizing rapid in-situ detection of specific 
biomolecular interactions such as probe-analyte binding. The capacitive 
biosensor presented here employs elevated AC potentials at a fixed frequency 
for impedimetric interrogation of the microelectrodes. Such an AC signal is 
capable of inducing dielectrophoresis (DEP) and AC electrothermal (ACET) 
effects, so as to realize in-situ enrichment of macro and even small molecules 
at microelectrodes and hence accelerated detection. Experimental study of the 
DEP/ACET-enhanced capacitive sensing method was conducted, and the 
results corroborate our hypothesis.  
This capacitive sensing method has been shown to work with various types 
and sizes of biomolecules (such as antibodies, virus and small molecules) to 
differentiate disease-positive samples from negative samples within or less 
than two minutes, while conventional assay would require multiple processing 
steps and take hours to complete. The results showed high accuracy and 
sensitivity. Overall, this capacitive affinity biosensor may form a basis for the 
development of a feasible point-of-care diagnostic platform for the detection of 
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Chapter 1. Introduction 
1.1 Biosensor: its future in your health and well-being 
The spread and epidemic of infectious diseases have posed tremendous 
burden to the whole world [1]. For example, human tuberculosis, caused by 
Mycobacterium tuberculosis, occurs in more than ten million people worldwide, 
and is estimated to be responsible for the death of two million people annually 
[2]. For wildlife and livestock, diseases like Johne’s disease [3] and mastitis [4] 
causes the reduction of milk production (in dairy cows), weight loss and 
premature culling clinically affected animals. Particularly, mastitis causes an 
estimated $1.7-2.0 billion USD annual economic loss to the US dairy industry. 
Worldwide, it is the most costly disease affecting the dairy industry, incurring 
economic losses estimated at $50 billion/year.  
In the developing world, the situation is even worse [5]. Infectious diseases 
are responsible for a massive death toll on the populations of developing 
countries every year. According to World Health Organization (WHO), 21% of 
childhood death in the Africa region is caused by pneumonia [6]; still in Africa, 
more than 25% of infants are likely to acquire AIDS in the first year of life if their 
mothers are infected with HIV [7]; moreover, diarrheal diseases are estimated 
to cause around 2.5 million deaths among children under 5 years old, of which 
more than 85% takes place in the world’s poorest places [8, 9]. 
In the face of such a harsh reality, organizations and nations are putting an 
increasing number of manpower and material resources towards understanding 
and negating the proliferation of infectious diseases [10-12]. Among all the 
efforts, the production of low-cost while practical diagnostic devices is one of 
the core tasks. Since only with appropriate diagnosis would we be able to 
perform the necessary therapy. Nevertheless, current diagnostic tools have 
fallen far behind the needs of the majority, especially in less developed areas. 
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For instance, most developing countries do not possess even half of the basic 
medical tools needed for routine health care [13]. In other words, the inabilities 
to provide practical low-cost devices for point-of-care diagnosis have limited the 
access to proper test and treatment for those that need them most [14, 15]. 
Recently, National Academy of Engineering (NAE) has listed healthcare as 
one of the grand challenges facing our global future. As of now, large 
percentages of vulnerable population are still seeking improved quality of life, 
which brings significant opportunity for technology to improve global health. For 
example, hassle free and comfortable health monitoring systems are always 
desired [16]; also, there is huge merging market space for disease diagnosis, 
especially if it can be done in early stage.  
As an integral and crucial part of all health services, point-of-care diagnosis 
tool stands out as a promising future in preventing or minimizing the spread of 
a virus or disease outbreak. Point-of-care diagnosis refers to the action of 
conducting simple and quick medical testing or treatment at the site of patient, 
which is usually accomplished by portable/handheld devices [17, 18]. In this 
regard, one attractive tool that is capable of providing instant information on a 
disease outbreak is biosensor [19]. Biosensor is a device designed to detect or 
quantify a specific biomolecule such as protein or DNA. It is well established 
that biosensors can be applied in various fields, including medical science [20-
22], food and water inspection [23-26], environment surveillance [27] and crop 
protection [28, 29]. In principle, biosensors offer the possibility of real-time 
monitoring, and the deployment of these devices in the field would provide a 
low-cost and rapid detection of diseases. A desired biosensor possesses some 








Table 1.1 Characteristics of a desired biosensor. 
 Affordable by those at risk of infection. 
 Sensitive (few false-negative results). 
 Specific (few false-positive results). 
 User-friendly (simple to perform by persons with little training). 
 Rapid treatment at the first visit and robust use without the need for 
special storage. 
 Equipment-free (that is, no large electricity dependent instruments 
needed to perform the test. 
 Delivered to those who need it. 
 
In addition, a medically relevant biosensor is highly desired to be able to 
realize more advanced functions such as multiplex sensing and intelligent data 
acquisition. As we can imagine, biosensors with aforementioned characteristics 
will have a giant impact on lifestyle related outcomes of infectious diseases.  
1.2 Biosensor: its major challenges 
Broadly speaking, there are two major types of biosensors: catalytic 
biosensor and affinity biosensor [30]. Catalytic biosensors measure the change 
in the concentration of target sample induced by the catalyzed reaction, they 
usually require the usage of certain enzyme [31]; while affinity sensors detect 
the occurrence of specific biomolecular interactions, such as antigen-antibody 
binding or DNA-DNA hybridization [32] . 
Between the two, catalytic biosensors have dominated the biosensor market 
for decades. For example, one of the most successfully commercialized 
biosensors is the biocatalytic electrochemical glucose sensor [33, 34], which 
has benefited millions of diabetic patients. On the other hand, affinity sensors 
are still largely limited to scientific publications, despite a few commercial 
products. In general, there are several challenges hindering the development 
of biosensors, most of which are direct against affinity sensors. 
Firstly, the detection with affinity biosensor is a two-step process: (1) 
immobilization of bioreceptor onto a solid surface and (2) detecting the 
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corresponding change in the surface properties [35]. The stability and activity 
of immobilized bioreceptor are therefore of vital importance in determining the 
overall performance of the biosensor. For the moment, despite that various 
approaches have been studied by different research groups aiming at 
improving the stability and uniformity of surface coating [36-40], immobilizing 
the bioreceptor onto selected sites while still retaining its activity remains as 
one of the top challenges facing the research of affinity sensors.  
Secondly, if a biosensor is to be employed for real-time diagnosis with 
complex reagents like blood or serum, the surface of the sensor must be 
durable and selective enough for the target analyte. Good selectivity (also 
known as specificity) [41] enables the detected signal change is caused by 
specific interactions instead of nonspecific ones. Selectivity is crucial in reality 
where target amount can sometimes be very limited and much less than 
interferences [42, 43]. Obtaining adequate selectivity in complex samples such 
as blood serum or saliva is another major challenge that has to be overcome 
before any practical use of biosensors. 
Thirdly, limit of detection is another challenging issue. Although many 
publications (biosensors) claim to be able to detect infectious diseases at very 
low levels [44-46], most of them are determined in the absence of non-target 
interferences. Since it is rare for such clean samples to be realistic in practical 
applications, reported limits of detection might be misleading in determining a 
biosensor’s real-world performance [35]. In real world detection, biosensors 
should be challenged with mixed target/nontarget analytes to verify its feasibility.  
Besides, other issues like usability, robustness and financial cost [47] are all 
possible limiting factors deterring the practical/commercial application of affinity 
biosensors.  
In this work, we will design, develop and validate a novel affinity biosensor 




 1.3 Dissertation Outline 
This dissertation is organized as follows.  
Chapter 2 introduces and compares various types of biosensors based on 
different sensing mechanisms. Basic concepts and principles regarding affinity-
based biosensing are also mentioned.   
Chapter 3 introduces the theory of electrochemical impedance 
spectroscopy and direct capacitive sensing.  
Chapter 4 introduces the basics of AC electrokinetics, including the 
importance of inducing ACEK to affinity biosensing and the three phenomena 
of ACEK. 
Chapter 5 first describes the concept of incorporating capacitive sensing 
and ACEK. Afterwards, the whole sensor development process is introduced, 
including the design and setup of sensing devices, the development of assay 
methods and the characterization of the capacitive affinity sensor. 
Chapter 6 presents the detection results of various types of samples, 
including antibodies, virus and small molecules. Detailed and in-depth assay 
development and optimization are also discussed in this chapter.  
Finally, the dissertation works are summarized and future works are 














Chapter 2. Literature review of 
biosensors 
 
In recent years, biosensors have attracted numerous research effort 
because of their potential to achieve rapid, inexpensive, and portable on-site 
diagnosis [48-51]. Yet the design of a feasible biosensor is not an easy task. It 
requires deep understanding of multidisciplinary topics including biology, 
material science, chemistry and electrical engineering [52]. This chapter 
introduces and compares various biosensors such as optical, electrochemical, 
piezoelectric and magnetic biosensors. In addition, basic concepts and 
principles of affinity-based biosensing are also mentioned.  
2.1 Various types of biosensors 
A biosensor is composed of two basic elements: a bioreceptor which 
enables specific biomolecular interaction and a transducer which converts the 
biointeraction into a measureable signal, such as a change in color. Based on 
different types of transducers being involved, biosensors can be classified as 
optical biosensor (e.g. fluorescence, surface plasmon resonance (SPR) and 
chemiluminescence), electrochemical biosensor (amperometry or 
potentiometry, cyclic voltammetry and impedance spectroscopy), piezoelectric 
biosensor, magnetic biosensor (e.g. giant magnetoresistive sensing) and etc. 
This section provides a brief overview of various biosensors aforementioned.  
2.1.1 Optical Biosensors 
Optical biosensors have been long studied, and some of them have already 
been adopted by the market [53, 54]. As the name implies, optical biosensors 
transform the biomolecular interaction into an optical signal, such as a change 




2.1.1.1 Fluorescent biosensors 
Fluorescence means the emission of visible light from any substance when 
it absorbs an excitation light of certain wavelength [55]. In fluorescent 
immunoassay [56], the detection of target biomolecule is done by using a 
“sandwich assay” [57]. Firstly the primary antibody is immobilized onto the 
sensor surface, then the secondary antibody which is labelled with fluorophores 
will be introduced to bind to the primary antibody. After washing away the 
unbound secondary antibodies, the surface will be excited with a light of certain 
wavelength so that fluorescence will be emitted and detected. Fluorescence 
biosensor can realize quantitative determination since the fluorescence signal 
is directly related to the concentration of bound antibodies. Figure 2.1 [58] 
demonstrates a fluorescence biosensor developed by some former members 
in our group, which successfully detected the binding of bovine serum antibody 
to pathogen specific antigen.  
 
 
Figure 2.1 Fluorescence biosensor developed by previous members of our 




Fluorescent immunoassay is one of the most widespread approaches in 
the field of optical biosensor because of its high sensitivity and selectivity. 
However, it requires multiple steps for antibody incubation and washing, making 
it too time-consuming, complicated and somewhat unreliable to be used for 
rapid point of care diagnosis. 
2.1.1.2 Surface Plasmon Resonance (SPR) biosensors  
SPR technique is an optical method which measures the refractive index 
of very thin layers of material adsorbed on a metal film [59]. To capitalize on 
that, SPR biosensor measures the change of refractive index at the fluid/solid 
interface before and after biointeraction, thus realizing the detection. SPR is 
very sensitive to binding since even a tiny increase in mass would lead to a 
proportional change in the refractive index at the fluid/solid interface. In this way, 
it could monitor the biomolecular interaction information on the substrate. 
Figure 2.2 [50] demonstrates the principle of a typical experimental 
configuration for SPR biosensor. A thin gold-film on a glass slide is the 
transducer, which is optically coupled to a glass prism for the measurement of 








The major advantage of SPR biosensors includes its high sensitivity and the 
ability to realize real-time detection without any label. However, albeit to the 
benefits, SPR biosensor often requires sophisticated optical instrumentation 
and highly trained personnel to operate, making it a costly and complicated 
method.  
2.1.1.3 Chemiluminescence (CL) biosensors 
Chemiluminescence is another extensively used optical detection scheme 
in immunoassays [60]. CL is the light produced by a chemical reaction. CL 
biosensor detects the appearance and/or concentration of samples based on 
the intensity of emitted luminescence. As schematically shown in Figure 2.3 
[50], samples A and B react with luminol (an intermediate), meanwhile the 
emitted light can be detected. 
 
 
Figure 2.3 Schematic view of CL detection. 
 
CL detection features a very low detection limit [61-63] and wide dynamic. 
In addition, compared with other optical methods, it does not require an 
excitation light instrumentation, which brings down the cost while eliminates the 
background interference. Nevertheless, as it still has a labelling step, CL 
detection is sometimes too complicated. Besides, the results could be affected 
by environmental factors such as temperature.  
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2.1.2 Electrochemical biosensors 
Electrochemical biosensors have always been an important part in the field 
of biosensing [64-69] . Most electrochemical biosensors feature high sensitivity, 
low cost, low power requirement and seamless integration with standard 
microfabrication process. Over the past decades, a large amount of 
publications and demonstrations of innovative detection schemes have been 
presented [70-73].  
Electrochemical biosensors work through the detection of an electric signal 
resulting from specific biomolecular interactions. Based on the signal 
generation principles, electrochemical biosensors are mainly categorized into 
three types: amperometric, potentiometric and impedimetric biosensor. This 
section provides an overview of these three methods respectively.  
2.1.2.1 Amperometric biosensors 
Amperometric sensing [49] is one of the most popular approaches among 
various electrochemical sensing methods. It is realized through the 
measurement of a current at a fixed (potentiostatic technique) or variable 
(voltammetric technique) potential [51]. Typical amperometric sensing involves 
a three-electrode system, as demonstrated in Figure 2.4 [51], which contains a 
working electrode, a counter electrode and a reference electrode. Current is 
generated at the working electrode by a redox reaction on the electrode surface. 
Redox reaction releases electron so that a current would be generated between 
the working electrode and counter electrode, which is proportional to the 
amount of the analyte. As the signal is relatively small, enzyme-labeled 





Figure 2.4 Schematic view of a common three electrode system (left) and 
actual device (right). 
 
As a simple and straightforward sensing method, technology about 
amperometry has matured comparatively in recent years. In fact, many 
commercially available point-of-care biosensing systems are based on 
amperometric detection [74-76]. Among them, electrochemical glucose 
biosensor based on amperometric sensing is regarded as one of the most 
successfully commercialized amperometric sensors.  
2.1.2.2 Potentiometric biosensors 
Potentiometric sensing detects the change on the surface charge or 
potential charge upon the occurrence of biointeraction at the interface of the 
sensor [48]. Analytes in aqueous solution possess a net charge polarity, which 
is related with the isoelectric points [77] of bioparticles and the ionic composition 
of the sample reagent. The formation of probe-analyte complex will change the 
net charge density compared with that of probe alone, which can be measured 
by a potentiometer. A reference electrode in the same solution is set at a 
constant potential as a reference.  
 
Aside from the change of net charge, the potentiometric signal can also be 
generated by changes in the pH or redox state. Broadly speaking, there are 
ion-selective electrodes (ISE) [78], field effect transistor (FET) [79, 80] , and 
light addressable potentiometric sensors [81]. As an example, Figure 2.5 [49] 
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demonstrates a FET potentiometric biosensor for the detection of human serum 
albumin (HAS) antibodies.  
 
 
Figure 2.5 An extended-gate FET biosensor for HAS antibody detection. 
2.1.2.3 Impedimetric biosensors 
Impedimetric biosensors are based on impedance measurements of the 
biosensing system [35, 82]. It can characterize the electrical properties of the 
system without destroying it. An alternating current (AC) signal is applied 
between a pair of working electrodes, in this way the electrolysis of the 
electrodes [83] can be eliminated, providing a more accurate and authentic 
readout. In a microfluidic immunoassay, the variation of the impedance caused 
by the biomolecular interaction can be measured by an impedance analyzer 
[84]. One of the greatest advantages of impedimetric sensor is that label-free 
detection could be easily realized. 
Recently, the research on impedimetric biosensors is directed in several 
directions [85], such as improving immobilization methods of receptors [86-89], 
exploring nanostructured electrode to amplify detection signal [39], and 
investigating equivalent circuit or data processing algorithm to effectively 
correlate analyte concentration with impedance change [90, 91] .  
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To sum up, compared with optical biosensor which normally requires 
specific and complicated equipment, most electrochemical biosensors can be 
readily fabricated from various conducting substrates using standard chip 
manufacturing methodologies. The relative low cost of electrochemical 
biosensor is one of the main reason that it is attracting extensive attention from 
both academia and industry. 
2.1.3 Piezoelectric biosensors  
When electric field is applied on the quartz crystal, mechanical deformation 
will be produced. On the contrary, when mechanical stress is applied, electric 
field will be generated [50]. This phenomenon is known as piezoelectric effect 
and the material with this characteristic is called a piezoelectric material [92].  
The basic equations describing the relationship between the resonant 
frequency of an oscillating piezoelectric crystal and the mass deposited on the 
crystal surface is known as the Sauerbrey equation [93]:  
∆F = −2.3 ∗ 106𝑓2
∆𝑚
𝐴
          (2.1),  
where F is the frequency change in oscillating crystal in Hz, f is the frequency 
of piezoelectric quartz crystal, m is the mass of deposited analyte, and A is 
the area of electrode surface. According to this equation, if biointeractions take 
place at the surface, the resonance frequency of the piezoelectric crystal would 
change based on the concentration of the analyte, thus quantitative analysis 
can be achieved. Figure 2.6 [94] demonstrated the schematic of piezoelectric 




Figure 2.6 Experimental apparatus of a typical piezoelectric biosensor. 
 
The most widely applied piezoelectric biosensor is quartz crystal 
microbalance (QCM), which is also known as “micro weighing instrument” [50, 
95]. It works based on the piezoelectric effect to measure the mass of change 
on the sensor surface without the usage of label. For a classic QCM, a thin 
quartz crystal is placed between two electrodes, which serve to generate an AC 
electric field across the crystal. Under the generated field, crystal will vibrate at 
its resonance frequency (usually around 10-50 MHz). The vibrational 
displacement of the crystal changes with mass loading, thus enabling the 
measurement of the change in the resonant frequency of the crystal. QCM is 
highly sensitive to mass. For instance, Su et.al [96] reported a QCM sensor for 
the detection of E.Coli O157: H7 with a detection limit of 103 CFU/mL. 
Compared with optical biosensors, piezoelectric biosensor does not require 
a labelling step, which is its biggest advantage. In addition, it features high 
sensitivity, real-time readout, and low cost. Nevertheless, the greatest limitation 
facing piezoelectric biosensor is its accuracy and repeatability, since it is 
extremely hard to achieve a uniform surface coating with piezoelectric materials.  
2.1.4 Magnetic biosensors 
Magnetic biosensing introduces magnetic beads as label particles (see 
Figure 2.7 [97]). After the occurrence of biointeractions, the formation of the 
biocomplex is measured by detecting the appearance of the magnetic particles, 
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which can be performed in several ways. A simple method to detect magnetic 
particles is to measure optically the fraction of the surface that has been 
covered, yet it does not exploit the magnetic features of the particle. To 
capitalize on that, a more general way is to detect the changes in the magnetic 
field caused by the presence of the magnetic particles, which is performed by 
using giant magnetoresistance sensor (GMRS) [98]. When magnetic particle 
gets close to a GMRS, the resistance of the magnetoresistor will decrease 
because the magnetic field is influenced by the magnetic particles. Figure 2.8 
[99] demonstrates a GMRS detecting the binding of streptavidin to biotin. It 
should be noted that magnetic particles need to be aligned, otherwise the 
magnetic field will cancel each other.  
 
 
Figure 2.7 Schematic of immunocomplex labelling with a magnetic particle. 
 
 





In addition, magnetic biosensors have been demonstrated in the detection 
of many other biological samples such as the antigen of Y.pestis [100], 
polycyclic aromatic hydrocarbons [101] and colorectal circulating cancer cells 
[102] with very low limit of detection. It is regarded as a good competitor for 
point-of-care applications but requires further developments with respect to 
fluidic delivery and usage with clinical samples. Another drawback of magnetic 
biosensors is the requirement of label, which further complicates the procedure.  
2.2 Comparison of different biosensing techniques 
Based on different sensing mechanisms aforementioned, here we listed the 
advantages and disadvantages regarding each type of biosensors in Table 2.1. 
 
Table 2.1 Advantages and disadvantages of different types of biosensors. 





High sensitivity; good 
stability; real-time 
detection 
Complicated steps; time 







trained personnel required 
CL 
Low detection limit; wide 
dynamic; relative low cost 
Complex procedure; label 







easy to integrate; 
Low sensitivity; poor stability. 




Label-free; low cost; easy to 
perform 
Lack of specificity 
Piezoelectric biosensors 
Ultra high sensitivity 
(pictogram level); label-free 
Poor repeatability; poor 
stability 
Magnetic biosensors 
Low detection limit; high 
sensitivity 
Label required; hard to be 
integrated into a platform. 
 
Compared with other sensing techniques, microelectrode impedimetric 
biosensing is rather advantageous due to its simplicity in operation and its low 
17 
 
cost in fabrication. Moreover, the ability to achieve in-situ detection without the 
requirement of labelling makes it even more promising towards the building of 
a reliable and feasible biosensor for real world diagnosis. 
2.3 Affinity-based biosensing 
Affinity biosensors detect biological particles based on specific binding 
between analyte and probe molecules, as schematically shown in Figure 2.9. 
Probe molecules, also known as bioreceptors, are first immobilized onto a solid 
surface prior to adding the analyte sample solution. The analytes of interest are 
then introduced and form probe-analyte complexes at the surface [103]. A 
transducer is involved to transform the biological interaction into a measureable 
signal (either optical, electrical or etc.), which can thus be measured by the 
appropriate instrument.  
 
 
Figure 2.9 Basic components of affinity biosensor. 
 
2.3.1 Important metrics 
Several important metrics used to judge the performance of a biosensor 
are sensitivity, specificity, reproducibility, reliability and etc. Sensitivity may refer 
: Sample analyte        
: Interfering molecules          
: Probe molecule        
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to two different concepts: one is the lowest detectable analyte concentration, 
which is more commonly known as the limit of detection (LOD) [104]; the other 
is how detection signal changes when the analyte concentration changes, i.e. 
the slope of the calibration curve [105]. In this work, sensitivity refers to the 
latter definition and it’s differentiated with LOD. Specificity, also known as 
selectivity, means the ability of the sensor to detect the analyte of interest while 
other interfering molecules are present, which is often the case of real biological 
samples. In addition, reproducibility represents the sensor’s ability to reproduce 
the same study by either the same person or a different researcher 
independently. Reliability, as a whole, depends on both the sensor’s specificity 
and reproducibility [65]. All of these aforementioned metrics would together 
determine the feasibility of a biosensor to be applied for real world diagnosis. 
2.3.2 Detection: label vs label-free; end-point vs real-time [103] 
Biosensors are able to provide a quantitative detection of analytes of 
interest, as the measurable signal is directly related to the concentration of the 
analyte. Depending on whether a label molecule is needed to generate a 
readable signal, analyte detection can be classified as labeled or label-free 
detection. Label molecules are molecules with unique properties such as 
fluorescent particles [106, 107], chemiluminescent particles [108, 109] or redox 
markers [70, 110]. Figure 2.10 shows an example of a horseradish peroxidase 
(HRP) labeled antibody, which is commonly used in immunoassay to as a signal 
amplifier [111, 112]. Prior to labeled detection, label molecules are attached to 
the analyte of interest, thus the detection of sample analyte can be achieved 
through the detection of label molecules. The usage of labeled detection usually 
enables much higher sensitivity, as the signal is enhanced by the unique 




Figure 2.10 An HRP labeled antibody conjugate. 
(Source: http://www.rockland-inc.com/custom-antibody-conjugation.aspx) 
 
Compared with labeled detection, label-free detection, which enables direct 
detection of analyte of interest, is attracting more attention in recent years [35, 
113, 114]. Labeling can sometimes be problematic. For example, it is difficult to 
label irregular or tiny molecules. Besides, labeling complicates the procedure 
and brings more uncertainty to the detection [115].  
Another way of classifying detection methods is based on the time point 
where actual detection occurs. End-point detection occurs after the 
biointeraction is stopped, it is a single point measurement of the probe-analyte 
complex. As a result, it causes more inaccuracy and only limited reaction 
information can be obtained. Real-time detection [116-118], on the other hand, 
measures the reaction continuously while the biointeraction is taking place, thus 
allowing instantaneous and more precise information.  
As we could tell, a label-free and real-time detection system [119, 120] 
would be more favorable towards the development of biosensors for practical 
applications. 
2.3.3 Affinity biosensors: prospective 
As mentioned in the Chapter 1.2, the majority of affinity biosensors are still 
under the level of academic researches either due to the lack of reliability or the 
excessive costs. However, compared with catalytic biosensors, affinity 
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biosensors are more versatile and flexible in terms of diagnosis applications. 
Catalytic biosensors require the usage of catalyst to trigger certain chemical 
reaction, which limits their application field and complicates their readout. On 
the other hand, affinity biosensors can detect any biointeractions happened at 
the sensor surface through various methodologies, thus enables a much 
broader application range.  
Despite current challenges, current researches regarding affinity biosensors 
have demonstrated their potential to become feasible and effective tools for real 


































Chapter 3. Basics of capacitive 
sensing 
3.1 Electrochemical Impedance Spectroscopy (EIS) 
Among various affinity-based sensing methods, impedimetric sensing is 
promising due to its reasonable cost, ease of operation and the ability to realize 
label-free and real-time detection. In this chapter, we start with the introduction 
of Electrochemical Impedance Spectroscopy (EIS), which stands as the 
fundamental of impedimetric sensing techniques.  
3.1.1 EIS introduction 
Electrochemical impedance spectrum [121-123] analysis is a well-
established method for characterizing an electrolytic cell. Usually a small signal 
perturbation is applied to the electrode across a wide frequency range, the 
corresponding magnitude and phase responses are measured and plotted as 
the impedance spectrum [103]. In EIS, a network of electronic components can 
be developed to represent an electrochemical cell. A change in the EIS spectra 
can be correlated with a change in the (di) electric properties near the 
electrode/electrolyte interface due to biomolecular interactions. The ability of 
realizing label-free detection with relatively easy configuration has made EIS a 
popular biosensing method for decades [124].   
3.1.2 Circuit network of electrode-fluid system 
The impedance of an electrode immersed in liquid can be approximated as 
a network of capacitive and resistive components, as conceptually shown in 
Figure 3.1. It consists of fluid resistance (Rf) and capacitance (Cf), which 
represents the resistance and capacitance from the bulk fluid; and charge 
transfer resistance (Rct) and interfacial capacitance (Cint), which origins from the 
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electrode/fluid interface. EDL refers to the electric double layer [125, 126], 
which usually forms at the electrode/fluid interface. EDL will be discussed in 
detail in the next section. The charge transfer resistance [127] is attributed to 
the interactions of ions in the solution with the electrons in the electrodes which 
produce a current. 
 
  
Figure 3.1 Circuit model of the electrode-fluid system. 
 
There are two types of electrochemical reactions: Faradaic reaction and 
non-Faradaic reaction. If charge transfer across the interface is cause by the 
flow of a DC current, it is regarded as a Faradaic reaction. For Faradaic reaction, 
charge transfer resistance is the dominating factor of the impedance response. 
On the other hand, if no DC current flows across the interface and the charges 
are associated with the movement of ions, the reorientation of dipoles [126] and 
etc., it is regarded as a non-Faradaic reaction. This work focuses on affinity 
sensing based on non-Faradaic reactions, in such cases, interfacial 
capacitance will dominate the impedance response of the system [103].  
Figure 3.2 shows an impedance spectrum of an electrode-fluid system, 
which is also known as the Bode plot [128]. Bode plot provides frequency 
related information, which can be related to the equivalent circuit model of the 
system: at low frequency range (usually <100 Hz), Rct dominates the 
impedance, therefore it favors the sensors base on Faradaic reaction; while at 
high frequency range (usually >1 MHz), the impedance will be dominated by Rf 
and Cf, which have almost zero impact to interface impedance. For affinity-
based biosensing, most biointeractions happen at the interface, therefore such 
high frequency range becomes inappropriate. Only at intermediate frequency 
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range (from several kHz upto several hundred kHz) will the impedance be 
dominated by interfacial capacitance, which serves as the proper frequency 
range for this work.    
 
 
Figure 3.2 Impedance spectrum of an electrode-fluid system. 
 
Another popular method for impedance presentation is Nyquist plot, where 
the real part of the impedance is plotted on the X-axis and the imaginary part is 
plotted on the Y-axis [129]. Figure 3.3 shows a Nyquist plot obtained using the 
proposed circuit model. Nyquist plot is mostly applied to sensors based on 
Faradaic reaction, as Rf and Rct can be easily determined from it [130]. As 
shown in Figure 3.3, the diameters of the two semicircles would be the value of 





Figure 3.3 Nyquist plot of an electrode-fluid system. 
 
3.2 Direct capacitive biosensing 
Albeit its usefulness, regular EIS requires complex data analysis to extract 
the relevant biological information. In recent years, direct capacitive biosensing 
has become an active embranchment of impedimetric sensing [131-133], as its 
ability to convert a signal of biomolecular interaction straight to a change in 
capacitance.  
3.2.1 Electric double layer  
When a solid material is immersed into an electrolytic solution, the solid 
surface will acquire surface charges. To maintain charge neutrality, a thin layer 
of counter ions is formed at the solid/liquid interface to neutralize the surface 
charges at the solid surface, which is commonly known as the electric double 
layer (EDL), as schematically shown in Figure 3.4 [126]. Electrically, EDL can 
be modeled as a capacitor. The layers of counter ions and surface charges are 
equivalent to the two plates in a capacitor, and the plate separation distance is 
the EDL thickness, which is characterized by Debye length (κ-1) [134]. Debye 
25 
 




-1), which is approximately the range that the applied potential can 
change the charge distribution in the bulk solution. This represents the range 
that the changes of charge distribution, due to biointeractions, can lead to the 
changes in interfacial capacitance [103].  
 
 
Figure 3.4 Schematic diagram of EDL together with the variation in potential 
with distance y from the surface. 
 
The value of Debye length is given by Eqn (3.1) [126]: 
             κ−1 = √
𝜀𝑘𝐵𝑇
2𝑧2𝑞2𝑛0
,                       (3.1) 
   where  is the permittivity of the electrolyte,  𝑘𝐵is the Boltzmann constant, 
𝑇 is the temperature, 𝑧 is the valence, 𝑞 is the charge on a single electron 
and 𝑛0 is the number density of charge. Debye length is inversely proportional 
to the electrical conductivity of the fluid. For most biological reagents, it is a few 




3.2.2 Interfacial capacitance  
Capacitive biosensors exploit the change in thickness or dielectric 
properties of the dielectric layer at the electrolyte–dielectric interface, which will 
lead to a change in the interfacial capacitance of the device upon the 
occurrence of biointeractions. 
The interfacial capacitor consists of a series connection of equivalent 
capacitors caused by EDL and biomolecule deposition. When biomolecules are 
adsorbed onto the electrode surface, the interfacial capacitance (Cint) will 
change due to the change in the thickness and surface area of Cint, which can 
then be used to indicate the deposition of biomolecules or particles on the 
electrode as well as to be correlated with the biomolecule or particle 
concentration in the fluid. The whole process is schematically shown in Figure 
3.5 (using antigen-antibody binding as an example).  
 
 
Figure 3.5 Changes at the electrode surface due to the binding of specific 
antibody to immobilized antigen. 
 
As schematically shown in Figure 3.5, at first the interfacial capacitance of 
bare electrode is given as:                
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            Cint,0 =  𝑠Aint λ𝑑⁄  ,                             (3.2) 
where 𝑠  is the permittivity of the solution, Aint  is the surface area of the 
interfacial capacitor of the electrode, and λ𝑑 is the thickness of the double layer. 
Then, after the electrode surface is deposited with antigens, the capacitance 
changes to:  
      Cint,ag =  Aa ((
1
𝑝
⁄ ) 𝑑𝑎𝑔 +⁄ (
1
𝑠
⁄ )λ𝑑) ,                  (3.3) 
where 𝑝 is the permittivity of the antigen probes. The relative permittivity of 
probe is around 2-3 [135] , while that for water solution is around 80. Aa is the 
surface area after antigen deposition, and 𝑑𝑎𝑔 is the antigen thickness. At last, 
after the antibody binding reaction, the dielectric layer becomes the sum of the 
EDL (λd), the antigen probe (𝑑𝑎𝑔), and the bounded antibodies (𝑑𝑎𝑏). As a result, 
the interfacial capacitance changes to: 
Cint,ab =  Ab [(
1
𝑝
⁄ ) (𝑑𝑎𝑔 + 𝑑𝑎𝑏) +⁄ (
1
𝑠
⁄ )λ𝑑] ,               (3.4) 
where Ab is the surface area of the interfacial capacitor after binding, 𝑑𝑎𝑏 is 
the antibody thickness. Subtracting Cint,ag by Cint,ab, we could get the relative 
change of interfacial capacitance caused by antibody binding (assuming 




= −𝑑𝑎𝑏/[(𝑑𝑎𝑔 + 𝑑𝑎𝑏) + (
𝑝
𝑠
⁄ )λ𝑑],   (3.5) 
Consequently, the surface binding, i.e. the addition of𝑑𝑎𝑏 , can be detected 
through ∆C/Cint,ag.  
Furthermore, since ∆C/Cint,ag can be directly correlated with the amount 
of bounded biomolecules on the electrode surface, capacitive sensing is a 
quantitative detection method to a certain extend. In reality, when measuring 
the impedance of an electrode/electrolyte cell, there always exist 
inconsistencies from sensor to sensor, mostly due to the variations in electric 
properties of real life samples and the bottom-up nature of surface 
functionalization. As a result, the baseline and initial capacitances will have a 
range instead of a well-defined value. Using the capacitance change rate, the 
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uncertainty in test results can be reduced, since the aforementioned test 
variations will largely be factored out. 
The aforementioned change of interfacial capacitance can be either 
positive or negative, as conceptually shown in Figure 3.6. Antibodies are 
deposited onto the surface because of binding. The thickness of the dielectric 
layer increases, which could cause a decrease in the interfacial capacitance 
(Figure 3.6a). On the other hand, randomly deposited antibodies could cause 
an increase in the interfacial capacitor’s surface area due to extra topology 
introduced by the antibody, especially when the probe (antigens) are spaced 
apart, leading to a higher interfacial capacitance (Figure 3.6b). Both changes 
could occur during the binding. Oftentimes, one type of change dominates over 
the other, then the detection of binding is possible.   
 
 
 (a)                                        (b) 
Figure 3.6 Two possible topology changes at the solid/fluid interface due to 
protein binding reaction. (a) The thickness of the interfacial layer increases 
while its surface area decreases, Cint reduces as a result; and (b) when the 
increase in the surface area of Cint dominates over the changes in its 
thickness, Cint increases. (Ab: antibody; Ag: antigen) 
 
The situation in Figure 3.6a, i.e. a decrease in Cint due to antigen-antibody 
binding, is more commonly observed [84]. In a diluted buffer, the EDL is 
relatively thick. As EDL envelops the antibodies on the electrodes, fine features 
on the scale of EDL thickness (dedl) will be lost, and the Cint change will be 
dominated by an increase in its thickness, i.e. Cint reduces. When EDL 
thickness is comparable to that of antibody topology, a positive change of Cint 
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is possible, especially in a buffer of high ionic strength [136].  
In this work, after a great amount of experiments, we found that both an 
increase and a decrease in Cint could possibly arise from probe-analyte binding, 
depending on the type of sample being tested. Preliminary experiments are 
conducted to support the above hypothesis about the interfacial capacitance 
change. Buffer of two different ionic strengths, 1 mM and 2 mM phosphate 
buffer saline (PBS), are used. The results corroborate that the EDL thickness 
(~nm) relative to the characteristic length of deposited macromolecules will 
determine whether a decrease or an increase in interfacial capacitance would 
result from binding reactions. The detailed results will be discussed in Chapter 
6. 
3.2.3 Capabilities 
In general, capacitive affinity sensing technique has two major functions: 
realizing the study of nanoscale surface structure and deposition; and carrying 
out the detection of specific surface biomolecular interactions. In this work, the 
first function is used for the monitoring surface quality of sensor electrodes, 
while the second function is applied to detect specific biomolecular interaction, 













Chapter 4. Basics of AC 
electrokinetics 
4.1 The importance of inducing ACEK 
Affinity-based biosensors typically rely on passive diffusion of analytes for 
binding reaction, which in many cases lead to long detection time and lack of 
sensitivity. It could take hours or even days for the amount of bound molecules 
to reach a detectable level [137, 138]. To achieve a useful sensitivity within 
practical time scales beyond what is dictated by the limitation of molecular 
diffusion, active guidance of biomolecules is needed to direct them to sensors. 
A number of strategies have been investigated to provide sample concentration 
in liquids, such as magnetic particles [139, 140] and optical tweezers [141, 142]. 
However, those methods are somewhat too complicated for POC testing [5]. In 
contrast, electrokinetic in-situ concentration of analytes can be seamlessly 
incorporated into capacitive detection to break the diffusion limit. 
Alternating current electrokinetics (ACEK), as a particle and fluid 
manipulation mechanism, has minimal requirements on the device fabrication 
and operation to be incorporated into a detection system, -- only 
microelectrodes and their AC signal source need to be added. This chapter 
introduces the three fundamental phenomena of ACEK [143]: dielectrophoresis 
(DEP), AC electroosmosis (ACEO), and AC electrothermal effect (ACET). 
Among them, DEP induces directional particle movement, while ACEO and 
ACET manipulate particles through fluid viscosity and gradients in local 
conductivity. An order of magnitude estimation of ACEK forces is also provided 




4.2 ACEK for particle and fluid acceleration 
AC electrokinetic microfluidics [126] emerged in the 1990s and has been 
intensively studied as a means to manipulate particles or macromolecules. It 
has been demonstrated by several groups [144-147] that ACEK working with 
microelectrodes can induce in situ concentration of particles for improved 
detection sensitivity and throughput. Initial studies in our group have 
investigated ACEK concentration of biomolecules by both numerical study [148] 
and experiments [149, 150]. ACEK effects exploit AC electric field to induce 
particle and fluid movement, so that biomolecules can be in-situ concentrated 
onto microsensors [151]. When an inhomogeneous AC electric field is applied 
to an aqueous solution, both particle movement and fluid microflows can be 
induced to transport particles. 
4.2.1 Dielectrophoresis (DEP) 
The manipulation of particles by DEP is based on the difference between 
the particle polarizability and that of the medium solution at a certain frequency 
[147]. When a particle is placed in a non-uniform electric field, electric field 
density on one side of the particle will be larger than that on the other side, 
which would lead to a net force on the particle. This force is called a DEP force. 
As shown in Figure 4.1 [152] , DEP force can either be positive (when the 
particle is more polarizable than its surroundings) or negative (when medium is 
polarizable than the particle). Positive DEP leads the particle to move towards 





(a)                               (b) 
Figure 4.1 Schematic illustration of DEP force: (a) positive DEP and (b) 
negative DEP. 
 


















,   (4.1) 
where 
* /j    
 is the complex permittivity with ε, σ and ω being 
permittivity, electrical conductivity and angular frequency; subscript p and m 







∗ ] is known as Clausius–Mossotti factor (fCM) and is frequency dependent 
with a value between -0.5 and 1. a is the particle radius; E is the electric field 
strength, and r is the distance to the center of the electrode gap. fCM determines 
the polarity of DEP force: when it is positive, the particle will experience positive 
DEP force, moving towards high electric field regions, such as electrode edges; 
when it is negative, the particles will experience negative DEP force, being 
repelled from electrodes. Positive DEP is employed for particle concentration 
in this work.   
4.2.2. AC electroosmosis (ACEO) and AC electrothermal (ACET) effect 
Based on Eqn (4.1), the magnitude of DEP force depends largely on the 
particle volume. In case of nanoscale biomolecules such as antibodies (small 
radius), DEP is effective only with high ∇|𝐸|2, i.e. high electric field gradient, 
which means that molecules need to be within a very short distance from the 
electrodes to experience sufficient DEP attraction, which can be difficult for 
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some circumstances. Fortunately, ACEO and ACET could work as a perfect 
complementation, inducing fluid movements which will carry molecules towards 
the electrode surface even from a long range. 
“AC electroosmosis refers to the microfluidic motions generated at 
electrode surfaces when AC signals are applied. It relies on the induction and 
movement of mobile charges in the double layer at electrode surfaces and 
typically happens at low frequencies when the interfacial impedance 
dominates.[143]” The schematic of ACEO flow is shown in Figure 4.2. Moreover, 
ACEO typically dominates at low ionic strength. The flow velocity of ACEO has 
been observed to decrease significantly with increasing conductivity and 
eventually drop to zero above 0.085 S/m [153]. For biological applications, the 
ionic strength of suspending medium must maintain a certain level so that 
biomolecules can stay alive. In this study, phosphate buffered saline (PBS) 
containing 15 mM Na+ is used as the medium, with a conductivity of 0.18 S/m, 
thus ACEO flow will be negligible. 
 
 
Figure 4.2 Schematic illustration of ACEO flow. 
 
To actuate fluid at such high conductivities, a feasible option is to use AC 
electrothermal effect. ACET has been demonstrated as a promising technique 
to manipulate conductive fluids [154-157]. The AC electrothermal effect results 
from the interactions of AC electric fields and temperature gradients in the fluid. 
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Therefore it favors higher fluid conductivity, since higher temperature gradient 
could be generated, leading to stronger ACET flows. 
ACET effect could exert volume force on fluid to generate microflows as: 
[153, 158] 







𝜋𝑟𝐸4,      (4.2) 
where 𝑀 is a dimensionless factor which predicts the variation of force with 
frequency: for frequencies lower than 1 MHz, i.e. 
𝜔 𝑚
𝛿𝑚
⁄ ≪ 1 , 𝑀 = +6.6, 
where 𝜔 is angular frequency. 𝑚 and 𝜎𝑚are the permittivity and conductivity 
of the fluid, respectively.  𝑉𝑅𝑀𝑆 is the RMS (root mean square) value of the 
applied voltage. 𝑘 is the fluid thermal conductivity; r is the distance to the 
center of the electrode gap and T is the temperature in Kelvin.  
The schematic of ACET flow is shown in Figure 4.3 [159]. At the frequency 
range of this work, ACET flow can be regarded as frequency-independent, and 
scales with the electric conductivity of fluid. With planar electrodes, ACET effect 
will induce vortices above each electrode, and the microflows will convect the 
embedded particles towards the electrode surface [160]. Because fluidic forces 
have no dependence on particle size (from Eqn (4.2)), ACET microflows will be 
well suited for transporting biomolecules to the electrodes. Furthermore, 
previous work by our group member Liu [58] have shown that ACET effect is 
playing an important role in increasing detection sensitivity. 
 
  
Figure 4.3 Schematic illustration of ACET flow. 
 
Combining DEP and ACET effect, nanoscale particles are collected over a 
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large range to the electrodes, so as to realize accelerated and sensitive 
detection of biomolecular binding reaction.   
4.2.3 Order of magnitude comparison: ACEK forces vs. natural forces   
For the purpose of showing the effectiveness of ACEK in flow acceleration 
and particle concentration, this section compares the relative magnitudes of 
different forces (i.e. ACEK forces and natural forces) and their induced flow 
velocities.  
First, an order of magnitude estimation of DEP and ACET forces is provided 
using Eqns (4.1) and (4.2), with parameters assumed to be close to the 
application purpose of this work. Table 4.1 lists the parameters involved in 
calculation.  
 
Table 4.1 Parameters involved in ACEK force calculation. 
 𝐄 = 𝑽 𝝅𝒓⁄ , r= 0.5 um. 
 Applied voltage: V= 1 Vrms. 
 Particle mass and size: molecular weight: 150 kDa, which is equal to 2.5e-22 
kg. Particle is assumed as spherical with radius of 10nm (a=10 nm) 
 𝐑𝐞[𝒇𝑪𝑴]=1, f= 100 kHz. 
 Permittivity of medium: 𝛆𝒎 = 𝜺𝒓𝜺𝟎 = 80*8.85e-12 F/m. 
 Electrical conductivity of medium: 𝛔𝒎= 0.18 S/m 
 Thermal conductivity of medium: k= 0.6 W/ (m*K). 
 Temperature: T=300 K. 
 Viscosity of medium: 𝜼= 1e-4 kg/ (m*s). 
 




2 ≈ 4.4 ∗ 10−16𝑁              (4.3) 
Then, according to Stokes’ law [161], DEP velocity is calculated to be: 
        𝑣𝐷𝐸𝑃 =
𝐹𝐷𝐸𝑃
6𝜋𝜂𝑎⁄ ≈ 20 𝜇𝑚/𝑠                  (4.4) 
As shown in Eqn (4.1), 𝐹𝐷𝐸𝑃  ∝  |E|
2, so if the applied voltage drops to 100 
mVrms, DEP velocity will drop to 0.2 𝜇𝑚/𝑠. 
   Based on Eqn (4.2), time-averaged volume ACET force on fluid is calculated 
to be:  
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| = 42 𝜇m/s           (4.6) 
   Since  𝐹𝐴𝐶𝐸𝑇  ∝  |E|
4, ACET velocity will drop to 4.2 nm/s if the voltage drops 
to 100 mVrms.  
Next, let’s consider the effect of natural forces. Gravity is the main external 
influence on a particle suspended in a fluid, which is given as:  
       𝐹𝑔 = 𝑉(𝜌𝑝 − 𝜌𝑚)𝑔 ≈ 0.2 𝑚𝑝𝑔 = 5 ∗ 10
−22𝑁,     (4.7) 
where 𝜌𝑝 and 𝜌𝑚 are mass densities of particle and fluid, respectively. 𝑚𝑝 is 
the mass of the particle. In practical cases, the factor 0.2 might be even smaller 
since many particles have densities close to water [153]. It is clear that 𝐹𝑔  ≪
𝐹𝐷𝐸𝑃, which means gravitational force is negligible compared to electrical forces. 
In addition, the effect of natural convection can also be neglected compared to 
electrical forces [158].  
Other than the aforementioned forces, diffusion driven by Brownian motion 
can also move particles [162]. Diffusion is non-deterministic, which means it 
could disrupt the directional movement of particles induced by ACEK. However, 
many literatures [144, 146, 159, 160] have shown that randomized diffusion is 
not strong enough to affect ACEK acceleration and concentration of sub-micro 
particles [158]. 
    To sum up, order of magnitude comparison of different forces proves the 
effectiveness of ACEK in flow acceleration and particle concentration, which 











Chapter 5. Sensor Development 
Having introduced the basic theories of capacitive sensing and AC 
electrokinetics movement, this chapter will move on to discuss the advantages 
of incorporating the two theories together for affinity biosensing. Furthermore, 
we will go into the details of device design and experimental considerations as 
we describe the development of the ACEK-based capacitive affinity biosensor. 
5.1 Incorporation of direct capacitive sensing and ACEK 
For the majority of the state-of-the-art impedimetric affinity biosensors, 
there are still some obstacles to be overcome for them to be used for POC 
detection. First, many impedimetric tests would require sophisticated and 
oftentimes time-consuming data processing to extract binding related 
information. Expensive benchtop impedance analyzers are usually needed if 
high test frequencies (>1 MHz) are used. Second, most of the reported 
impedance assays were conducted with highly processed samples. To be 
viable as a POC diagnostic system, sample preparation must be simple enough 
to be performed on site. Third, as mentioned in Chapter 4, most of the currently-
tested systems still require at least 30 minutes to perform a single incubation 
step with abundant molecules or even longer time for more diluted analyte. 
While this is an improvement over standard enzyme-linked immunosorbent 
assay (ELISA) method [163], an incubation time of half an hour or more may 
still be too long under some field testing circumstances. For example, testing 
multiple wild animals in field would be much more feasible if a more rapid test 
becomes available. 
In this work, a novel affinity biosensor is developed by incorporating 
ACEK effect seamlessly with the signal interrogation process for in situ 
biomolecule enrichment and real-time biointeraction process monitoring 
through direct capacitance measurement. Unlike conventional impedimetric 
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sensing, which uses a low AC voltage of 5-10 mV before and after the 
occurrence of biointeraction, the ACEK-based capacitive sensor reads the 
electrode impedance continuously with a fixed AC signal at a specific frequency, 
which is predetermined based on the biological reagents and sample types 
being tested. Such an AC signal would be able to break the diffusion limit by 
inducing ACEK effects to convect/attract biomolecules to the electrode surface, 
as shown in Figure 5.1. Meanwhile, the applied signal would stay in the “safe” 
range, i.e. minimum electrochemical reactions or other impedimetric artifacts 
will be involved as interferences.  
 
 
Figure 5.1 Breaking the diffusion limit by inducing ACEK. 
 
Furthermore, it should be noted that the same AC signal is used to 
measure the capacitance (and its change) between microelectrodes, which 
directly indicates the activity and level of biointeractions occurring on the 
microelectrodes. So in the ACEK-based capacitive assay, analyte enrichment 
and capacitive detection are conducted simultaneously. Incorporation of ACEK 
with sensors has been investigated for various types of sensors, such as 
microcantilevers [164], fluorescent labeled affinity sensing [58], quartz crystal 
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microbalance [165], and most commonly seen, impedimetric sensing [166-168]. 
For all the aforementioned reports, the ACEK concentration step is separate 
from the detection step, which is more complicated to operate than the 
capacitive assay developed in this work.  
Incorporating direct capacitive sensing with ACEK effect, the ACEK-based 
capacitive affinity biosensor can be very effective in enriching biomolecules 
concentration over a large range and thus realizing accelerated detection at 
real-time.  
5.2 Device design 
This section covers the details about sensor design and instrument setup, 
which includes elaborate information about the electrodes and the 
measurement devices. 
5.2.1 Preparation of microelectrode sensor 
The ACEK-based capacitive affinity biosensor utilizes arrays of coplanar 
interdigitated microelectrodes, which are obtained in two ways: 1) By modifying 
commercially available electrode chips, i.e. surface acoustic wave (SAW) 
resonator chips (PARS 433.92, AVX Corp). 2) By in-house fabricating gold (Au) 
coplanar microelectrodes on silicon wafer. Images of original and modified SAW 
chips are shown in Figure 5.2a, and the scanning electron micrograph (SEM) 
of the interdigitated electrode array in the SAW chip is shown in Figure 5.2b. 
Meanwhile, images of in-house fabricated gold electrodes are shown in Figure 
5.3 (a) and (b).  
The reason we choose such type of electrode design is that similar 
interdigitated microelectrodes have been used by both our previous group 
members [148] and other groups [169, 170] to study ACEK effects, and it is 
proved to be very effective at generating DEP effect for particle enrichment as 






(a)                       (b) 
Figure 5.2 (a) Commercially available electrode chips, i.e. surface acoustic 
wave (SAW) resonator chips (PARS 433.92, AVX Corp). The left one is 
modified for immunosensing. (b) A scanning electron micrograph of the 
microelectrode array in the SAW chip. 
 
 
   (a)                      (b) 
Figure 5.3 (a) In-house fabricated gold microelectrodes on silicon wafer with a 
silicone chamber on top of it; (b) SEM image of the interdigitated array inside. 
 
The preparation of sensors involves chip modification (if needed) and 
electrode cleaning. Let’s first focus on the preparation of SAW electrode chips 
The first task is to remove the metal cover of the device to expose the 
working electrode array for use. This is done by using an X-Acto knife to first 
pierce the top cover near the edge of the chip. After piercing, the next step is to 
pry up on the lid to break the edge loose, then cover will be able to be sliced 
down. The metal casing around the electrode chip is about 4mm (L) x 2.5mm 
(W) x 1mm (H) = 10 µL, serving as a microchamber for sample solutions. The 
interdigitated electrodes are made of aluminum deposited on quartz substrate. 
Each microelectrode is 1.4 μm wide, 170 μm long, 200 nm thick, and separated 
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by a 1.1 μm gap from one another, as shown in Figure 5.2b. The interdigitated 
electrodes are electrically connected to two contact pads on the chip bottom, 
which will be connected to an impedance analyzer for measurement.  
Next, the SAW electrode chips are cleaned with the following procedure: 
1. Soak the chips in acetone for 20 minutes. 
2. Rinse the chips with isopropyl alcohol (IPA) for 30 seconds. 
3. Rinse the chips with purified water for another 30 seconds. 
4. Blow-dry the devices with clean air for 10 seconds to remove excess 
liquid. Use lab air to blow dry chips.  
5. Put the chips into UV Ozone cleaner (BioForce®) for 15 minutes. 
The modified SAW resonator will be denoted as SAW electrodes in later 
sections. 
For gold electrodes on silicon wafer, the fabrication process is described 
briefly as follows: 50 nm of gold is deposited on top of silicon substrate which 
has 100 nm of SiO2 as insulating layer and 10 nm of chromium (Cr) as adhesive 
layer. The fabricated microelectrode arrays have interdigitated configuration 
with two different dimensions, symmetric electrodes with a characteristic length 
of 2μm (with widths of 2μm separated by 2μm gaps), denoted as 2μm gold 
electrodes, and asymmetric electrodes with a characteristic length of 5μm (with 
widths of 5μm and 25μm separated by 5μm and 25μm gaps), denoted as 5μm 
gold electrodes. The size of the contact pad of each chip is 3 mm* 4mm. After 
fabrication, the whole wafer will be diced and each gold chip will be taken down 
as an individual sensor, as could be seen in Figure 5.4. 
 
 





The preparation of gold chip electrodes on silicon is easier, as the working 
electrodes are already exposed. The cleaning procedure for gold chip 
electrodes is described as follows:  
1. Sprinkle acetone on top the chip, wipe the surface with a clean non-
woven wiper for several times. 
2. Sprinkle isopropyl alcohol on top the chip, wipe the surface with a 
clean non-woven wiper for several times. 
3. Sprinkle purified water on top the chip, wipe the surface with a clean 
non-woven wiper for several times. 
4. Blow-dry the devices with clean air for 10 seconds to remove excess 
liquid. Use lab air to blow dry chips. 
After electrode cleaning, a silicone microchamber (2.5mm in diameter and 
0.9mm in depth, JTR24R, GraceTM Bio-labs) is sealed onto the wafer with 
electrodes inside for sample loading, as shown in Figure 5.3a and 5.4. The 
liquid amount within the chamber is also around 10 µL, similar to that of SAW 
electrodes. In addition, the microchamber is sufficiently high, so that electric 
fields and ACEK effects can fully develop, as shown by numerical simulation 
[148]. 
The cleaned SAW electrodes/gold electrodes on wafer will then be saved 
for surface functionalization, which is going to be discussed in later sections. 
5.2.2 Test fixture and instrument setup 
In this work, impedance data is acquired using a high precision impedance 
analyzer (Agilent® 4294A) with its 16047E test fixture, and the data is recorded 
through its LAN port onto a computer using software Data Transfer V3.0 
(SEKONIC®), as shown in Figure 5.5.  
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Figure 5.5 Agilent 4294A with 16047E test fixture connected with a data 
acquisition computer. 
 
For SAW electrode chips, in order to connect the sensor electrodes to the 
16047E fixture, two connection wires are soldered to pins on the back of each 
chip, as shown in Figure 5.6. The soldered chips will then be connected to the 
test fixture of the impedance analyzer. 
 
 
Figure 5.6 Connection of SAW chip to the test fixture. 
 
   In terms of making connection of gold electrode chips, a custom build fixture 
is designed for the chips to be mounted, as shown in Figure 5.7. Then the 
custom build fixture will be connected to the impedance analyzer. 
16047E    
4294A    
Data acquisition 




Figure 5.7 Connection of gold chip to the test fixture. 
 
5.3 Assay methods 
    With sensors and measurement instruments being introduced, this section 
moves on to the discussion of assay methods step by step, including electrode 
surface cleaning, surface functionalization with probes, surface blocking and 
analyte detection method. 
5.3.1 Electrode surface cleaning 
The quality/cleanness of electrode surface plays an essential part in 
determining whether a sensor is usable for biomolecular detection or not. Any 
residue or interference remained on the surface might lead to a failure in 
detection. Different electrode surface qualities (levels of cleanness) may quite 
likely be manifested through the interfacial capacitances, due to variations in 
the composition of dielectric layer, surface topologies or the ability to acquire 
surface charges. In this work, various electrode cleaning methods are 
conducted and their effectiveness are manifested through reading the 
interfacial capacitance values, demonstrating the capability of capacitive 
sensing described in 3.2.3. 
Before moving on to further discussion, it is worth mentioning that two types 
of surfaces may exist: 
1. Fresh surface, which means the surface has not been treated with any 
chemicals or biological stuffs. In this case, the major purpose of cleaning 
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is to remove any dirt or impurities that might come from fabrication or 
environment. Normally a mild wash is enough. SAW electrode has more 
concerns to obtain a clean fresh surface since it involves lots of 
modifications. For gold electrodes on wafer, the cleaning for fresh 
surface is a largely standardized procedure. 
2. Used surface, which means the surface has been treated with 
chemicals or biological stuffs. In this case, the goal is to recover the 
surface to its fresh state.  
Surface cleaning in this section refers to the cleaning of fresh surfaces with 
the focus on SAW electrodes.  
As listed in the explanatory text of Figure 5.8, three different cleaning 
methods have been tried to clean SAW electrodes. After each trial, interfacial 
capacitances of bare electrodes are measured with an excitation signal of 5 
mVrms. 0.1x phosphate-buffered saline (PBS), which refers to 1 mM phosphate 
buffer (pH 7.0) containing 15 mM NaCl, is used as measuring buffer for 
capacitance measurement. PBS is a buffer commonly used in biological studies, 
which is isotonic and non-toxic to bioparticles. 
For SAW electrodes, since reactance at 100 kHz represents closely that of 
the interfacial capacitor, capacitance values at 100 kHz are adopted as the 
indicator of the interface conditions. Strong correlation between the interfacial 
capacitance values and the cleaning methods has been found, as shown in 




Figure 5.8 Capacitance values with different washing methods. For each 
condition, five chips are measured. 
 (1): no wash 
(2): wash with DI water only 
(3): wash with acetone-IPA-DI water 
(4): wash with acetone-IPA-DI water-Ozone cleaner 
 
Lowest capacitance values are found when no wash is applied. Capacitance 
values gradually increase with the addition of cleaning steps, particularly 
noticeable between methods (2) and (3), (3) and (4). This could be explained 
by the hypothesis that before cleaning, the electrode surface is covered by a 
thin film of dielectrics (possibly from unintended growth or deposition of 
contaminants or other materials), while with added/more aggressive cleaning, 
the thickness of the film is reduced or the area covered by the film is getting 
less. According to C=εS/d (d is the thickness of surface film), with d decreasing, 
C would certainly increase. As a result, we choose method (4) for cleaning the 
electrodes, as has already been mentioned in 5.2.1. 
The cleaning of gold electrode surface mentioned in 5.2.1 is the widely 




5.3.2 Surface functionalization 
For affinity-based biosensors, prior to analyte detection, a layer of probe 
molecule needs to be immobilized onto the electrode surface to realize 
biospecificity. This step is known as surface functionalization. The quality of 
surface functionalization is crucial to the successful detection of analyte, as it 
determines the number of available binding sties. Generally speaking, there are 
two types of surface functionalization methods: passive adsorption and the 
usage of linker molecules. In this work, both of these methods are adopted and 
their effects are compared. 
5.3.2.1 Passive adsorption 
Biomolecules can be directly attached to metal surface due to the 
hydrophobic and electrostatic interactions between each other [103, 136]. 
Passive adsorption of probe molecules, also known as direct attachment, is the 
simplest way of functionalizing a surface, which involves only the incubation of 
electrodes with a solution containing the probe molecules for a certain period 
of time (usually several hours to overnight). 
For passive adsorption, the major concern is functionalization time. 
Incubation time could largely influence the quality of the probe layer. Therefore, 
in order to seek the optimal incubation time, a commonly used protein molecule 
(bovine IgG whole molecule) labelled with fluorescent dyes (concentration: 100 
ng/mL, diluted in 0.1x PBS) are immobilized on 5μm gold electrodes for different 
amount of times (6hrs, 12hrs and 24hrs). After washing away any unbound 
molecules, the electrodes are observed under a confocal microscope (Nikon® 














Figure 5.9 (a)-(e) Microscopic images of incubated electrodes. Left column 





















   
(a) Control- blank electrode 
   
(b) Control- electrode incubated with 0.1xPBS solution 
    
(c) After 6 hours of incubation with IgG 
   
(d) After 12 hours of incubation with IgG 











   
(e) After 24 hours of incubation with IgG 






















For PBS diluted protein molecules, it is clear that six hours incubation 
produces a relatively stronger and more uniform surface functionalization. Thus 
six hours is adopted as the functionalization time for passive adsorption for PBS 
diluted molecules. While for ethanol diluted probe molecules, since it is not able 
to process a fluorescent label, we choose the most widely applied 
immobilization time in a traditional ELISA test [171], which is overnight (~16 hrs).  
Although biomolecules can be immobilized to the electrode surface 
through passive adsorption, it has several limitations [103]:  
1. Hydrophobic and electrostatic bonds are weak bonds. As a result, 
biomolecules can be easily removed from the surface using certain 
solvents or detergents.  
2. The surface coverage by passive adsorption might be low especially for 
biomolecules with different shapes, sizes and orientations [82].   
3. It is hard to realize uniform coating by passive adsorption. 
5.3.2.2 Usage of linker molecules 
Compared to passive adsorption, the usage of linker molecules serves as 
a better surface functionalization method, as it is able to form strong covalent 
bond between biomolecules and electrode surface. Moreover, linker molecules 
tend to form self-assembled monolayers (SAM) on the electrode surface, which 
possess well-defined composition, structure and thickness [172-174]. 
Therefore a uniform coating is more likely to be realized by applying linker 
molecules. 
Thiols and polysiloxanes have been widely applied as effective linkers for 
probe immobilization [175, 176]. Functional thiol groups are commonly used on 
gold surfaces because they have thiol compounds (S-H groups) which possess 
very strong affinity to gold surfaces [172]. On the other hand, polysiloxanes are 
more frequently used on metal oxide surfaces, as they could form SAMs on 
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metal oxide surface by silanol (-Si-O-) and siloxane (-Si-O-Si-) [177]. 
In this work, SAW electrodes are made of aluminum, which is easily 
oxidized under its neutral state. As a result, 3-aminopropyltroethoxysilane 
(APTES) [178], as one of the most extensively used polysiloxanes, is applied 
as the linker molecule for SAW electrodes. While for gold electrodes, functional 
thiol groups are applied as the linker molecules. Figure 5.10 shows the 
chemical structures of APTES (a) and thioctic acid (b), which is a commonly 
used functional thiol linkers [103]. 
 
  
(a)                             (b) 
Figure 5.10 Different types of linker molecules. (a) APTES and (b) thioctic 
acid. 
 (Source: 3-Aminopropyltriethoxysilane | 919-30-2". Chemicalbook.com. Retrieved 2012-08-01.) 
 
5.3.2.2.1 APTES treatment 
As schematically shown in Figure 5.11, on one end, APTES has non-
hydrolysable hydroxyl groups which can bond strongly to metal oxides; on the 
other end, it has amine groups that can form strong interaction with amino group 
in biomolecules [179]. Therefore, biomolecules would form a much more stable 





Figure 5.11 Schematic of APTES treatment of a substrate. 
 
After a fair amount of trial, the procedure for APTES treatment for SAW 
electrodes is set as follows: 
1. Cleaned SAW electrodes are exposed to 10v/v% APTES in absolute 
ethanol for 15 minutes under room temperature.  
2. The electrodes are rinsed with 96% ethanol three times, dried with air 
gun and then baked at 125°C for 30 min.  
3. The electrodes are incubated with 2.5v/v% glutaraldehyde for 1 hour at 
room temperature. Glutaraldehyde is used to modify the chemical 
reactivity of the formed SAMs [175]. 
4. The electrodes are washed with DI water for three times. 
5. The electrodes are incubated with solution containing probe molecules 
(protein in this work) for five hours in a humidor at room temperature. 
6. The electrodes are washed with 0.1x PBST, which is 0.1x PBS 
containing 0.05 v/v% Tween 20 (Fisher Scientific, Pittsburgh, PA), for 
three times to remove any unbound probe molecules 
 
Similar to that of electrode surface cleaning, the effectiveness of APTES 
treatment is checked through reading the capacitance values, as shown in 
Figure 5.12. As could be seen, APTES-treated chips showed much smaller 
capacitance, since most part of the electrode surface is covered by non-
hydrolysable hydroxyl groups and amino groups, causing the loss in its 




Figure 5.12 Comparison of capacitances between washed bare SAW 
electrodes and APTES-treated SAW electrodes. Five chips are measured and 
their capacitance values are plotted. 
 
5.3.2.2.2 Thiol mediation 
As aforementioned, thiol linker has S-H groups at their terminal ends which 
could form strong bond with the gold surface. Meanwhile, the head group of 
thiol linker is carboxylate group, which could be further activated for 
biomolecule binding. 
In this work, the formation of functional thiol groups is described using 3-
MPA (3-mercatopropionic acid), which is a commonly used thiol linker: (Figure 
5.13 gives a schematic of the thiol formation and activation.) 
1. Cleaned gold electrodes are modified by immersion of 1mM 3MPA and 
50 mM PBS buffer (pH =10) for 17 hours to form a self-assembled 
monolayer with carboxylate termination. Alkaline pH is employed to 
increase the solubility of 3-MPA in PBS buffer. 
2. After 17 hours, the electrodes are cleaned with distilled water.  
3. The terminal carboxylate groups are then activated for 1 hour in 75mM 
EDC and 15 mM NHS [180] in 50 mM PBS buffer (pH=7.3). After 
EDC+NHS activation, ester groups in NHS will be able to form strong 
covalent bond with the amino group in biomolecules. 
4. The electrodes are then cleaned with 0.1x PBST for three times. 
SAW aluminum electrodes 
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5. The electrodes are then immersed for two hours into a solution 
containing probe molecules and 50 mm PBS at pH 7.3, forming amide 
bonds to the protein surface. 
6. The electrodes are then cleaned with 0.1x PBST for three times to 





Figure 5.13 Schematic of thiol SAM formation and activation with NHS+EDC. 
 
Again, the effectiveness of thiol mediation is also checked by reading 
their capacitance values, as shown in Figure 5.14. Compared with bare gold 
electrodes, thiol-mediated electrodes showed smaller capacitance values, 
which proves that the thiol groups are functional. 
 
 
Figure 5.14 Comparison of capacitances between washed bare gold 
electrodes and thiol-mediated gold electrodes. Five chips are measured and 
their capacitance values are plotted. 
                  
After formation of thiol 
SAM.               
Activation of SAM with 





  Here we summarizes and compares the pros and cons of passive adsorption 
and the usage of linker molecules, as shown in Table 5.1.  
 
Table 5.1 Comparison between passive adsorption and linkers. 
Passive Adsorption Linker molecules 
Simple to operate, easy to be 
removed 
More complex to operate; harder to be 
removed 
Weak bond: hydrophobic and 
electrostatic interactions. 
Can easily be reversed. 
Strong bond: covalent bond between 
molecules and surface. Irreversible.  
Low surface coverage, especially for 
proteins and antibodies. 
Well-defined composition, structure 
and thickness. Enables more stable 
and uniform coating. 
 
Effects of different functionalization methods will be compared in Chapter 6 when 
related analyte detection results are mentioned. 
5.3.3 Surface blocking  
After surface functionalization, surface blocking will be performed to cover 
any unoccupied space on the electrode surface to minimize non-specific 
binding. In this work, blocking buffer used is buffer B, which is PBS-T containing 
10 v/v% SuperBlock (PIERCE Biotechnology, Rockford, IL). Different blocking 
times and concentrations of blocking reagent (0.1x, 0.2x or 1x) might cause 
different impacts towards analyte detection. The impact of blocking will also be 
discussed in Chapter 6.   
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5.3.4 Analyte detection 
After surface functionalization and blocking, the probe-coated electrodes 
will be washed with 0.1x PBST to remove any unbound molecules. Then the 
electrode chips will be connected to the impedance analyzer and analyte 
samples will be introduced to the surface for detection. 
When sample analyte is introduced, the interfacial capacitance of the 
electrode is continuously measured at a predetermined frequency for a certain 
period of time (from 15 seconds to 2 minutes, depending on the binding activity). 
ACEK-based capacitive affinity sensing method adopts a dimensionless 
quantity – the percentage change in the measured capacitance to indicate 
analyte deposition onto the electrode, which is the slope of normalized 
capacitance change versus time (%/minute) and found by least square linear 
fitting method [181]. Normalized capacitance is calculated as  
Norm (Cint, t) = Cint, t/ Cint, 0, where Cint, t and Cint, 0 are the measured 
interfacial capacitances at time t and time zero, respectively. Doing so 
circumvents the need for a reference sensor, minimizes size difference from 
sensor to senor, further simplifying the detection procedure and instrumentation. 
5.3.5 Summary 
Overall, the basic steps of the capacitive affinity biosensing is summarized 
in Figure 5.15.  
 
 
Figure 5.15 Summary of assay procedure. 
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5.4 Sensor Characterization 
In the development of the capacitive affinity biosensor, impedance spectra 
analysis of the electrode-fluid system is conducted to determine which circuit 
elements would predominately account for the biomolecular interaction. As 
mentioned in Chapter 3, EIS analysis is a well-known characterization method 
for impedimetric based affinity sensor to relate the biomolecular interaction with 
corresponding changes in electric signals.  
5.4.1 Extracting the values of circuit elements 
Upon the occurrence of biomolecular interaction, impedance spectra of the 
electrode-fluid system would change accordingly. By fitting the impedance 
spectra with the proposed equivalent circuit model, biomolecular interaction 
would be corresponded to changes of resistance and/or capacitance values of 
the model.  
Since SAW electrodes and gold electrodes have different materials and 
designs, values of circuit elements would be different between the two types of 
sensor. 
SAW electrodes are first examined. 0.1x PBS is adopted as measuring 
buffer. 10 ng/mL goat anti-bovine IgG antibody (analyte) binding with 
immobilized bovine IgG (probe) is used to represent biomolecular interaction. 
Before and after the analyte binding step, impedance spectra of the electrode-
fluid system are recorded at 5 mVrms from 10 kHz to 1 MHz, a range of the 
most interest to our detection. The proposed equivalent circuit model is 
employed for curve fitting and extracting component values. The measured 
impedance spectra together with fitted curves are shown in Figure 5.16, with 





Figure 5.16 Comparison of measured impedance spectra and curve fitting 
using the four element equivalent circuit model of SAW electrodes. 
(Frequency range: 10 kHz-1MHz. Signal applied: 5 mVrms.) 
 
Table 5.2 Equivalent circuit parameters obtained by curve-fitting the 
experimental results for SAW electrodes. 
Steps Rct(Ω) Cint (nF) Rf(Ω) Cf (pF) 
Before binding 750 30 1750 3 
After binding 800 24 1850 3 
 
Of the four circuit elements listed in Table 5.2, Rct and Cint describe the 
electrical properties at the electrode-fluid interface, while Rf and Cf describe the 
properties of the bulk fluid. Since the enrichment effect by ACEK is the most 
pronounced at 100 kHz, it is adopted as the testing frequency in our ACEK 
impedance sensing. At 100 kHz, the reactances for Cint and Cf are calculated 
to be ~53 Ω (<<Rct) and 530 kΩ (>>Rf), respectively. It can be seen that Cint and 
Rf dominate the impedance response for the frequency of interest to this work 
(100 kHz). Consequently, the equivalent circuit in the inset of Figure 5.16 can 
be simplified to a series connection of Rf-Cint as shown in the inset of Figure 
5.17. In Figure 5.17, the impedance responses from the Rf-Cint serial connection 
are plotted along with the measured impedance spectra, and good agreements 




Figure 5.17 Comparison of measured impedance spectra and curve fitting 
using simplified Rf-Cint serial connection for SAW electrodes. (Frequency 
range: 10 kHz-1MHz. Signal applied: 5 mVrms.) 
 
For gold electrodes, impedance spectra of the electrode-fluid system are 
recorded from 100 Hz to 1 MHz at 5 mVrms with 0.1x PBS as measuring 
solution. The measured impedance spectra together with fitted curves are 








(a)                                    (b) 
Figure 5.18 Comparison of measured impedance spectra and curve fitting of 
gold electrodes. (a) Using the four element equivalent circuit; (b) Using Rf-Cint 
serial connection. (Frequency range: 100 Hz-1MHz. Signal applied: 5 mVrms.) 
 
Table 5.3 Equivalent circuit parameters obtained by curve-fitting the 
experimental results for gold electrodes. 
 Value 
Impedance 
(reactance) at 100 kHz 
Rct 20 kΩ 20 kΩ 
Cint 120 nF 13 Ω 
Rf 80 Ω 80 Ω 
Cf 0.2 nF 94 kΩ 
 
As shown in Table 5.3, at 100 kHz, the reactances for Cint and Cf are 
calculated to be ~13 Ω (<<Rct) and 94 kΩ (>>Rf), respectively. Therefore, it is 
also true that Cint and Rf dominate the impedance response of gold electrodes 
at the frequency range of our interest. 
Besides, it is worth mentioning that the impedance of the gold electrodes 
after loading sample is measured to be in the range of 80-100 Ω at 100 kHz, 
and the impedance analyzer used for capacitance measurement has an internal 
resistance of 25 Ω. Thus, loading effect cannot be neglected for gold electrodes, 
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i.e. the output voltage from the impedance analyzer is divided between the 
sensor and analyzer, and the actual voltage applied onto the sensor is lower 
than the nominal voltage set for the impedance analyzer. To obtain the actual 
voltage drop, an oscilloscope (Agilent DSO3062A) is connected to the sensor 
during measurement. The measured voltages show around 30% decrease from 
the nominal measuring voltage for gold electrodes. Table 5.4 gives the actual 
voltage drops corresponding to the displayed voltages on the impedance 
analyzer. On the other hand, the impedance of SAW electrodes is over 1 kΩ, 
so the loading effect is negligible (<2% drop). 
 
Table 5.4 Measured voltage drop on gold electrodes. 
 (Unit: mVrms, rms: root mean square) 
Nominal voltage 50 100 200 400 500 1000 
Actual voltage 43 81 142 275 338 655 
 
5.4.2 Simplified equivalent circuit  
The above analysis shows that for the frequency range of interest to this 
work (around 100 kHz), a serial connection of Rf and Cint could adequately 
account for the impedance presented by the microelectrode/electrolyte system, 
with Cint predominantly responsible for the biointeraction process. 
Correspondingly, impedance value measured by the impedance analyzer is in 
the form of Zmeas = R-jX = R +
1
jωCmeas
⁄ , where R and X are the real part and 
imaginary part of the measured impedance, respectively. From the imaginary 
part, a capacitance value of Cmeas =
1
ωX⁄  can be found for a preset angular 
frequency. Based on the above discussion of the electrode impedance spectra, 
Cmeas corresponds approximately to Cint. Therefore, the change in Cmeas can be 
directly used to indicate the biomolecule deposition on the electrode surface, 




   In this chapter, we discussed the theoretical advantages of incorporating 
direct capacitive sensing with AC electrokinetics induced fluid and particle 
movement, which is the capability to realize rapid real-time and label-free 
detection of biomolecular interactions. We also described the two types of 
sensor electrodes: SAW aluminum electrodes and gold electrodes on silicon 
wafer. Furthermore, we discussed the assay procedure step by step, including 
different methods of electrode surface cleaning and various options for surface 
functionalization. Quality check of surface cleaning and functionalization by 
reading capacitance values proves their effects. Finally, EIS characterization 
showed that an Rf-Cint serial connection is able to represent the electrode-fluid 















Chapter 6. Results of analyte 
detection 
6.1 Sample and assay description 
In this chapter, detections of different types of analytes using the ACEK-
based capacitive affinity sensor are presented and discussed. As listed in Table 
6.1, three types of analytes are briefly described, each of which has its own 
research or realistic significances. More specifically, antibody includes anti-
bovine IgG, Johne’s disease (JD) serum and Human& Bovine tuberculosis (hTB 
and bTB) serum; virus refers to Influenza A virus; and small molecule includes 
Bisphenol A (BPA) and Progesterone (PG). More of their research or realistic 
significances will be mentioned when the specific assay is discussed.  
 





Simple and straight binding, highly 
specific and sensitive [182]. 
Johne’s disease (JD) 
serum sample 
One of the most economically important 
diseases of livestock [183]. 
Human & Bovine 
Tuberculosis(TB) 
serum sample 
A chronic infectious disease affects a 
broad range of mammalian hosts 
including human and cattle [2]. 
Virus 
Influenza A (Flu A) 
virus sample 




Bisphenol A (BPA) 
Exposure of BPA could probably cause 
adverse health issues to humans[185]. 
Progesterone(PG) 
Progesterone level can be an indicator 
towards pregnancy [186]. 
 
Moreover, Table 6.2 provides an overview of each assay by briefly 
describing the probes and target analytes, the types of sensor used, surface 
functionalization method and the sample diluent of each assay. Again, more 
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We start this chapter by discussing anti-bovine IgG antibody detection. 
Afterwards, the detection of two types of serum antibodies (JD and TB) is 
presented. Influenza A virus detection is then discussed with focus on the 
usage of linker molecules. Finally, small molecule detection is discussed.  
6.2 Bovine IgG antibody interaction 
6.2.1 Proof-of-concept 
Immunoglobulin G (IgG) is the most common type of antibody found in blood 
and extracellular fluid [187], it has a well-defined “Y” structure with two available 
antigen binding sites. As a proof-of-concept experiment, we study the specific 
binding of goat anti-bovine IgG (H+L) antibody (unlabeled) to bovine IgG whole 
molecules using our SAW electrodes. Both the bovine IgG whole molecule and 
anti-bovine IgG antibody are purchased from Jackson ImmunoResearch, West 
Grove, PA: 
 CromPure bovine IgG whole molecule, Jackson ImmunoResearch, 
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cat#001-000-003, stock 10 mg/mL. 
 AffiPure Goat anti-bovine IgG (H+L), Jackson ImmunoResearch, 
cat#101-005-003, stock 2 mg/mL. 
The experimental procedure is described as follows: 10 μL of bovine IgG 
whole molecules at concentration of 10 µg/mL (diluted in 0.1x PBS) is first 
added on cleaned SAW electrodes as probe molecule, and the SAW electrodes 
are then kept in a humidor for six hours for surface functionalization under room 
temperature. After surface functionalization, the electrodes are washed with 
0.1x PBST for three times and then blocked with 0.1x buffer B for 30 minutes. 
The electrodes are then connected to the impedance analyzer and anti-bovine 
IgG antibody samples will be introduced to the surface. Anti-bovine IgG 
antibodies are tested at concentrations from 10 ng/mL to 1000 ng/mL (diluted 
in 0.1x PBS). An AC signal of 100 mVrms at 100 kHz is then continuously 
applied for two minutes and the corresponding capacitance change versus time 
is recorded. In addition, the same experiment is repeated with doubled PBS 
concentration, i.e. 0.2x PBS, which means 1 mM phosphate buffer (pH 7.0) 
containing 30 mM NaCl. 
Figure 6.1 presents the curves of normalized capacitance changes versus 
time for three IgG concentrations in both 0.1x and 0.2x PBS. During the tests, 
the interfacial capacitances changed linearly with time. No saturation or 
depletion of the antibodies can be observed from these curves within the 2-
minute detection period. The slopes of these capacitance curves, i.e. the 
fractional capacitance change rates (‰/min), are calculated as a quantitative 
indication of antibodies bounded to the electrode surface. It can be seen that 
the fractional capacitance change rate shows strong correlation with the 
concentration of antibody. 0.1x and 0.2x PBS are test as the negative control, 
which gives a change rate of 2.14 ‰/min for 0.2x PBS and -1.17 ‰/min for 0.1x 
PBS. The magnitude of capacitance change consistently increases with 
increasing concentration of IgG antibody. With 10 ng/mL IgG antibody, the 
change rates are 12.36 ‰/min for 0.2x PBS and -6.01 ‰/min for 0.1x PBS. At 
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1000 ng/mL IgG antibody, the change rates increase to 49.10 ‰/min for 0.2x 
PBS and -30.72 ‰/min for 0.1x PBS.  
 
 
Figure 6.1 Normalized capacitance change as a function of time within two 
minutes for three different concentrations of bovine IgG antibody (10, 100 and 
1000 ng/mL) in 0.1x PBS and 0.2x PBS respectively. The boxed-in numbers in 
the figure are the fractional capacitance change rates of different IgG 
concentrations. 
 
It should be noted that the change of capacitance with antibody binding 
can either be positive or negative. As has been theoretically discussed in 
Chapter 3, we hypothesize the reason to be the difference in separation among 
different probes, with the difference in their length scale comparable to EDL 
thickness. Theoretically, due to the stronger ionic strength, 0.2x PBS has a 
thinner EDL than 0.1x PBS. So by varying the ionic strength of buffer, it 
effectively changes the relative gap between the bounded antibodies. The 
results shown in Figure 6.1 support our hypothesis regarding the causes of 
change in interfacial capacitance, as antibodies diluted in 0.1x PBS consistently 
yields a decrease in capacitance, while antibodies diluted in 0.2x PBS yields an 
increase in capacitance. 
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6.2.2 Impact of electrode design on detection 
In Chapter 4, we discussed ACEK and its possible effects towards binding 
detection. In theory, ACEK induced fluid flow and particle movement are related 
with the electrode design as well as the electric field strength being applied. In 
this section, we discuss the impact of different electrode designs. The impact 
of electric field strength will be discussed in the next section. Still, we use the 
binding of goat anti-bovine IgG antibody (analyte) to bovine IgG (probe) to 
represent the biomolecular interaction. Both of them are diluted in 0.1x PBS. 
To demonstrate the impact of electrode designs on biomolecule enrichment 
and detection, sensor responses from three types of electrodes are obtained 
under similar electric field strength for a range of antibody concentrations. 
Three sensing electrodes used are SAW electrodes (i.e. 1μm electrodes), 2μm 
gold electrodes and 5μm gold electrodes on silicon wafers. The experimental 
procedure is the same as described in 6.2.1. The characteristic electric field 
strength for a sensor is estimated as the applied voltage divided by the half 
circle over narrow electrode gap (E = 𝑉 𝜋𝑟⁄ , r is the distance to the center of the 
electrode gap). The electric field strengths are 50 mV/μm for SAW electrodes 
and 46 mV/μm for gold electrodes.  
Figure 6.2 shows the responses of the three different electrodes to various 
concentrations of IgG antibody samples. To account for possible artifacts from 
applying electric signal to biological samples, buffer without analytes is tested 
on functionalized electrodes as negative control experiments. In addition, to 
demonstrate specificity, non-specific binding tests with sample solution 
containing 10 ng/mL antibody are performed on un-functionalized electrodes. 




Figure 6.2 Antibody binding responses from three different electrodes under 
similar electric field strength. Each test is repeated three times. Error bar 
indicates the standard deviation. Control results include both buffer and non-
specific binding on un-functionalized electrodes. 
 
As shown in Figure 6.2, the capacitance change rates are very similar 
between SAW electrodes and 2μm gold electrodes for all the concentrations 
tested (1, 5, 10 and 100 ng/mL), while 5μm gold electrodes exhibited much 
larger responses. The SAW and 2μm gold electrodes have a logarithmic 
dependence on IgG concentration ranging from 1 to 100 ng/mL. Their 
sensitivities are found by linear curve fitting to be −0.59 ± 0.12 and −0.49 ±
0.07 %/log (ng/mL) with a Pearson correlation coefficient R2 [188] of 0.88 and 
0.94 for SAW and 2μm gold electrodes, respectively. In comparison, 5μm gold 
electrodes yield a sensitivity of −1.80 ± 0.69 %/log (ng/mL), more than three 
times that of SAW and 2μm gold electrodes. The 5μm gold electrodes exhibit 
logarithmic dependence on IgG concentration from 1 to 10 ng/mL, however, 
there is no increase in sensor response when the IgG level becomes higher 
than 10 ng/mL, probably due to saturation of binding sites by strong ACEK 
enrichment. As the electric field strengths are similar between the electrodes, 
so the differences between their output magnitudes can only be attributed to 
the electrode geometric differences. According to Eqns (4.1) and (4.2), DEP is 
more pronounced with smaller electrodes, while ACET effect favors larger 
microelectrodes. Since SAW and 2μm gold electrodes have similar output, it 
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may be concluded that DEP and ACET effect are comparable for electrodes 
with a characteristic size of 2μm and less. While for larger electrodes, ACET 
force will dominate, which is demonstrated by the significant improvement in 
the sensitivity of 5μm gold electrodes over 2μm electrodes.   
Relatively speaking, the negative control experiments using blank buffer 
exhibit very little responses. SAW electrodes, 2μm gold electrodes and 5μm 
gold electrodes show capacitance change rates of 0.01 ± 0.09 %/min, −0.03 ±
0.03 %/min and 0.21 ± 0.05 %/min, respectively. The outputs of non-specific 
binding tests on un-functionalized electrodes are a little larger, but still show 
little capacitance changes, −0.19 ± 0.10 %/min for SAW electrodes, −0.09 ±
0.03 %/min for 2μm gold electrodes and −0.26 ± 0.01 %/min for 5μm gold 
electrodes, which attests to the specificity of our tests. Also, based on Figure 
6.2, sensor output more positive than −0.30%/min is defined as being non-
reactive, i.e. negative response.  
6.2.3 Impact of electric field strength 
The impact of the applied electric field strength on IgG antibody binding 
detection is studied in this section using gold electrodes, with AC electric field 
strength ranging from 13 mV/μm to 86 mV/μm. This helps to establish a range 
of electric field strength for effective improvement by ACEK effects. Binding 
detection results of 10 and 100 ng/mL IgG antibodies on both 2μm and 5μm 





Figure 6.3 Binding responses of control buffer, non-specific, 10 ng/mL and 
100 ng/mL IgG samples under different electric field strengths. Both 2μm and 
5μm gold electrodes are tested for comparison. Each test is repeated twice 
and the error bar indicates standard deviation. 
 
From Figure 6.3, it is first noted that at 13 mV/μm, the sensor responses are 
small for all cases, even for 100 ng/mL sample on 5μm gold electrodes. This 
indicates that this electric field strength is too low to induce sufficient ACEK 
effects to effectively enhance binding reactions. For 5μm gold electrodes, the 
change rates are slightly more negative than −0.30%/min, the cut-off point for 
a detection. Second, it is evident that the capacitance change rate increases 
steadily with electric field strength, indicating that binding is aided by AC electric 
field, which strongly supports that AC electric field can induce usable DEP and 
ACET effects. Third, the difference in the responses between 2μm and 5μm 
gold electrodes widens quickly at higher electric field strength, which is 
consistent with Eqn (4.2) of ACET force 𝐹𝐴𝐶𝐸𝑇 ∝ 𝑟|𝐸|
4, especially for responses 
to 10 ng/mL antibody samples. So it is clear that enrichment by ACET effect is 
more dominant in larger electrodes. Last, the rate of increase in sensor 
response becomes less when the electric field strength goes above 45 mV/μm, 
especially for 5μm gold electrodes. So the range of AC electric field strength 
can be estimated to be between 13 and 45 mV/μm for effective induction of 
ACEK enhancement in affinity sensing.  
Furthermore, it should be noted that if the electric field strength is higher 
than 45 mV/μm, ACEK effects become so strong that sufficient analyte 
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molecules are transported close to the electrodes, and the surface binding 
shifts from transport-limited domain to reaction-limited domain. The outputs 
from 5μm electrodes are strongly indicative of saturation of binding sites. There 
is little difference between its response to 10 and 100 ng/mL IgG samples, and 
there is no increase in sensor response at electric field higher than 45 mV/μm.   
A comparison of the output transients between 2μm and 5μm gold 
electrodes shows that ACET flows are the cause of binding saturation, as 
shown in Figure 6.4. For 2μm gold electrodes at 86 mV/µm, as shown in Figure 
6.4a, the decrease in capacitance consistently becomes larger with more 
concentrated IgG samples. The interfacial capacitance decreases linearly with 
time with little indication of saturation.  However, for 5μm gold electrodes, 
saturation begins to show for IgG above 10 ng/mL even at 45 mV/μm. The 
change rate in normalized capacitance becomes larger as IgG concentration 
increased from 1 ng/mL to 5 ng/mL and 10 ng/mL. For 100 ng/mL, the 
capacitance initially dropped quickly then became more gradual after 10 
seconds, which is indicative of slowdown in binding reaction. At 86 mV/μm, the 
indication of saturation kinetics became much more pronounced. The 
capacitance curves for 10 ng/mL and 100 ng/mL overlap each other and 
asymptotically approach a maximum of capacitance change, which is 




























                                   
 
(b)                                      (c) 
Figure 6.4 Normalized capacitance change with time. (a) 2μm electrodes 
measured at 86 mV/µm; (b) 5μm electrodes measured at 45 mV/µm; (c) 5μm 
electrodes measured at 86 mV/µm. 
 
ACET effect is expected to be more obvious for detecting diluted analyte 
since longer range of enrichment is involved. In fact, sample enrichment is more 
highly desired for diluted samples. Table 6.3 shows the capacitance change 
rate of 1 and 5 ng/mL IgG sample at 10-second time periods. It can be seen 
clearly that binding events change from transport-limited for 2μm gold 
electrodes or at lower electric field to reaction-limited at higher electric field for 
5μm gold electrodes. In the first 10 seconds, 2μm gold electrodes show a 
capacitance change rate of  0.40 %/min. As time goes by, the change rate 
becomes more negative from −0.29 %/min in 10-20 seconds to −0.82 %/min 
in 20-30 seconds, which indicates increasing binding rate as a result of 
2μm electrode @ 86 mV/μm     
5μm electrode @ 45 mV/μm     
5μm electrode @ 86 mV/μm     
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biomolecules being gradually transported to the vicinity of electrode surface. 
Similar situation is shown for 5μm gold electrodes at 45 mV/μm. In comparison, 
it is a different scenario for 5μm gold electrodes at 86 mV/μm. At 1 ng/mL, its 
change rate is −1.13 %/min  in the first 10 seconds and slows down in 
subsequent time periods, indicating a faster transport of analytes at 86mV/μm 
than at 45 mV/μm. At 5 ng/mL, the Cint change rate is fairly constant, probably 
because there are plenty of analytes for binding. It is clear from Table 6.3 that 
larger electrodes are better at enriching analytes and the enrichment effect is 
caused by AC electric field. Both the much larger response and its transient 
behavior of 5μm gold electrodes indicate that 5μm gold electrodes can induce 
much stronger ACEK effect, mostly ACET effect, to enhance detection of more 
diluted analytes. 
 
Table 6.3 dC/dt (%/min) of 1 and 5ng/mL for every 10 seconds. 
 
From a physics viewpoint, electric field of 2μm or smaller electrodes is 
concentrated around the electrode corners and between the electrodes, while 
electric field of 5μm electrodes could reach further into the fluids. ACET effect, 
as a body force, need some distance away from solid phase to effectively 
generate convection [189]. Otherwise, the friction from the solid surface will be 
overwhelming (no slip boundary condition). Consequently, 5μm electrodes is 
able to generate much stronger ACET convections than 2μm electrodes, which 
in turn provides a much larger signal. 
 
Conditions 0-10 sec. 10-20 sec. 20-30 sec. 
2μm@86 mV/μm (1 ng/mL) 0.40 -0.29 -0.82 
5μm@45 mV/μm (1 ng/mL) -0.04 -0.67 -1.53 
5μm@86 mV/μm (1 ng/mL) -1.13 -0.56 -0.66 
5μm@86 mV/μm (5 ng/mL) -0.90 -1.42 -1.37 
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6.2.4 Determination of LOD  
With the limit of detection (LOD) being defined as more than three standard 
deviations from that of control tests, the LODs of SAW and 2μm gold electrodes 
are found to be 10 ng/mL (their capacitance change rates at 10 ng/mL are 
−0.50 ± 0.04 %/min and−0.50 ± 0.04 %/min. In contrast, 5μm gold electrodes 
showed a change rate of −0.60 ± 0.13 %/min for 1 ng/mL IgG sample. So the 
LOD for 5μm gold electrodes is 1 ng/mL, increasing by approximately one order 
of magnitude from SAW and 2μm gold electrodes. 
6.3 Detection of antibody in serum 
   In this section, we will move on to the detection of more complex serum 
samples. Serum is a blood component collected after blood has coagulated. It 
contains various types of proteins, including antibodies [190]. In this work, three 
types of serum samples with realistic significances are tested: Johne’s disease 
(JD) serum sample, human tuberculosis (hTB) serum sample and bovine 
tuberculosis (bTB) serum sample. 
   Johne’s disease is a chronic disease of mainly ruminants leading to 
granulomatous enteritis, persistent diarrhea, progressive wasting and finally 
death [191, 192]. The disease is distributed globally among domestic ruminants 
and wildlife species [193, 194]. 
   Tuberculosis (TB) is also a chronic infectious disease that affects a broad 
range of mammalian hosts including humans and cattle. Human TB is 
estimated to cause more than two million deaths every year. Although bovine 
TB, caused by Mycobacterium bovis, has been mostly eradicated in the 
livestock industry of developed countries, the disease in wildlife still poses a 
risk to livestock, tourism economy, and wildlife conservation. Global economic 
losses from bovine TB total US$ 3 billion annually. In developing countries, 
bovine TB still causes serious concerns not only for wildlife, but also for public 
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health, food safety and the economy of livestock industries. 
Conventional methods of chronic diseases diagnosis are labor-intensive, 
time-consuming and/or expensive. For example, medical evaluation of human 
TB includes a medical history, physical examination, radiographic imaging 
(conventional chest X-ray), microbiological smears, and bacterial cultures. It 
may also include a tuberculin skin test or other measurements of cellular 
immunity, such as interferon-gamma release assays (IGRA). For human TB, 
the Cepheid Xpert MTB/RIF assay has recently been used for on-site diagnosis 
but the assay is costly [195, 196]. Bovine TB in animals is commonly confirmed 
by post mortem examination of gross lesions and bacterial culture. Global 
control and prevention of TB has partly been hampered by the lack of effective 
diagnostic methods, so there is an urgent need for more simple, rapid and 
sensitive on-site diagnosis of TB [5]. 
It should be noted that both JD and TB serum samples are composed of 
mixtures of complex fluids, hence the exact antibody concentrations of these 
complex serum samples are unknown. 
6.3.1 Sample preparation 
6.3.1.1 Johne’s disease antigen and serum samples 
The preparation of Johne’s disease specific antigen and serum samples is 
described as follows: 
    Johne’s disease (JD) specific antigen: A bacterial pathogen 
Mycobacterium avium subsp. paratuberculosis (MAP), which is the 
causative agent of JD, is used to extract antigen as described previously 
elsewhere [197]. MAP is obtained from Dr. John P. Bannantine in the 
USDA/NADC (Ames, IA) and is cultured in Middlebrook 7H9 medium 
(Becton Dickinson Microbiology Systems, Franklin Lakes, NJ) with 10% 
OADC (oleic acid-albumin-dextrose-NaCl) (Becton Dickinson Microbiology 
Systems, Franklin Lakes, NJ). The medium is supplemented with 2 µg/mL 
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of Mycobactin J (Allied Monitor, Fayette, MO). The cultures are maintained 
at 37°C without shaking until they reach an optical density of approximately 
0.7 at 600 nm. MAP is harvested from the liquid culture at stationary phase 
and centrifuged at 2,600 × g for 10 minutes; the pellet is resuspended in 
80 % ethanol, agitated by vortex at room temperature for 2 minutes, and 
centrifuged at 10,621× g for 10 minutes. The supernatant is then collected, 
diluted in 100 % ethanol (1:80 v/v) and used as antigen for this assay. 
    Johne’s disease serum sample: Ten JD-positive serum samples are 
obtained from 10 different dairy cows (breed: Holstein; average age: 2.8 
years old; gender: female) tested positive for JD by bacterial culture and 
ELISA [171]. Ten JD-negative serum samples are obtained from 10 different 
cows (breed: Holstein; average age: 2.4 years old; gender: female) tested 
negative for JD by the procedures mentioned above. The bovine serum 
samples used in this work are kindly provided by National Animal Disease 
Center, USDA, Ames, IA. For testing, the serum samples are diluted with 
0.1x PBS before use. 
6.3.1.2 Human and Bovine tuberculosis specific antigens and serum samples 
The preparation of human and bovine tuberculosis specific antigens and 
serum samples is described as follows: 
    Human tuberculosis (hTB) specific antigen: Purified protein derivative 
(PPD) of Mycobacterium tuberculosis (Accurate Chemicals, NY) is adopted 
as the probe molecule and immobilized at a concentration of 10 µg/mL 
(diluted in 0.1x PBS). 
    hTB serum samples: A total of 11 human serum samples are obtained 
from the WHO (World Health Organization/Tropical Diseases, Special 
Programme for Research and Training) and tested for hTB. Six of these 
samples are obtained from patients tested positive for hTB based on prior 
TB history and bacterial culture results. Five of these samples are obtained 
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from patients tested negative for hTB based on the above mentioned tests. 
Serum samples are diluted in 0.1x PBS before testing. 
    Bovine tuberculosis (bTB) specific antigen: A virulent strain of 
Mycobacterium bovis (HC2005T), which is originally isolated from an M. 
bovis infected dairy cow, is cultured in Middlebrook’s 7H9 medium with 
addition of 0.05% Tween 80, 10% oleic acid-albumin-dextrose-NaCl at 37℃. 
For antigen preparation, M. bovis bacilli is harvested from stationary phase 
cultures, suspended in 80% ethanol (80 mg wet weight of bacteria/mL) and 
agitated by vortex to dislodge surface antigens. The dislodged M. bovis 
antigen is diluted (1:80) in the ethanol solution and used as antigen in this 
assay.  
    bTB serum samples: A total of 10 badger serum samples are provided 
by Animal Health and Veterinary laboratories Agency (AHVLA), UK. The 
bovine TB positive samples (n=5) are obtained from badgers which had 
previously tested positive for M. bovis by bacterial culture from clinical 
samples collected ante mortem and by ELISA for interferon-gamma. The 
negative serum samples (n=5) are obtained from animals from a region of 
the UK considered free from M. bovis infection in badgers and which are 
confirmed to be negative for bTB through repeat testing by the procedures 
mentioned above. Serum samples are diluted in 0.1x PBS before testing. 
6.3.2 Proof-of-concept 
For proof-of-concept, one of each of the JD positive and negative samples 
are tested using SAW electrodes to demonstrate the capability of distinguish 
serum positive/negative samples. The experimental procedure is described as 
follows: 10 μL of JD specific antigen is coated on cleaned SAW electrodes for 
overnight (16hrs) under room temperature, then the functionalized electrodes 
are washed with 0.1xPBST for three times and blocked with 0.1x buffer B for 
30 minutes. JD negative serum sample is diluted in 0.1x PBS with a volume 
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ratio of 1:20, while JD positive serum sample is diluted with 0.1x PBS with a 
volume ratio from 1:20 to 1:200 dilution for proofing quantitative detection as 
well. An AC signal of 100 mVrms at 100 kHz is continuously applied as the 
measuring signal for 200 seconds.  
Theoretically, disease positive serum samples contain higher 
concentrations of antibodies that will specifically bind to the antigens from the 
causative agent of the disease. Therefore, disease positive serum samples 
should exhibit larger change of Cint than disease negative samples.  
The normalized capacitance change rates for various dilutions of JD positive 
sera are plotted in Figure 6.5, negative serum sample and buffer are tested as 
control groups. The slopes of these capacitance curves, i.e. capacitance 
change rates, are also shown in the plot. As shown in Figure 6.5, the 
capacitances of JD negative serum sample and PBS stay rather constant 
during the test, while that of JD positive serum sample decreases monotonically 
with time due to specific recognition of serum antibodies. For the positive 
sample diluted at 1:20, the capacitance change rate reaches −54.6 ‰/min. 
While for negative sample and PBS, the related numbers are only −1.6 ‰/min 
and  −2.6 ‰/min , respectively. The low capacitance change rate of the 
negative sample indicates that signal interferences from non-specific 
interactions are at a very low level.  
Furthermore, as expected, when the sample becomes more diluted, the 
capacitance change rate decreased from −54.6 ‰/min at 1:20 dilution to 
−1.1 ‰/min at 1:200 dilution. Highly diluted sera (e.g. 1:160 dilution and 1:200 
dilution) cannot be differentiated from the control tests. For JD positive serum 
samples with dilution from 1:120 to 1:40, the normalized capacitance change 
rate shows a logarithmic dependence on serum dilution. The dependence could 
be expressed as: 
y (‰ 𝑚𝑖𝑛⁄ ) ≈ −73.7 log (serum dilution) − 157.5,     (6.1) 
with Pearson correlation coefficient R2=0.912. The results demonstrate that the 
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ACEK-based capacitive affinity biosensor is a quantitative method within a 
range of antibody concentrations.  
 
 
Figure 6.5 Transient behavior of normalized capacitances of JD serum 
samples. The samples are various dilutions of JD positive sera (1:20 to 
1:200), negative sera (1:20) and 0.1x PBS (control). 
 
6.3.3 Signal optimization 
Furthermore, as discussed in the detection of bovine IgG antibody, if the 
short “sample to results” time is a result of AC electrokinetics enrichment, then 
the capacitance change rate should exhibit a certain dependence on the 
applied AC signal. Therefore, as a reinforcement to the proof-of-concept 
experiments, binding of JD positive serum samples are tested under different 
AC signals using SAW electrodes, following the same experimental procedure 
described before. 
Firstly, the frequency of the signal is fixed at 100 kHz while the amplitude is 
varied from 5 mVrms to 500 mVrms. The capacitance change rates are 
obtained and plotted in Figure 6.6a as a function of voltage amplitude. As could 
be seen, with JD positive serum, the capacitance change rate increases 
monotonically with the magnitude of AC signals. The change rates from the 
positive sample are significantly higher than those from the control samples 
except for the results at 5 mVrms, while the change rate remained consistently 
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low (< ±3.7 ‰/min) for the control experiments (0.1x PBS) during the same 
voltage range. It indicates that 5 mVrms is too low to induce any ACEK effects 
to enhance specific biointeractions between antigens and antibodies. With 5 
mVrms applied, the capacitance change rate is merely −5.2 ± 0.8 ‰/min, only 
slightly higher than that of the control samples, which is  −3.7 ± 2.1 ‰/min. 
Such a small difference between JD positive serum sample and the control 
sample would not warrant an accurate detection of specific binding. Meanwhile, 
the capacitance change rate increases rapidly when the applied voltage 
increased from 5 mVrms to 100 mVrms. The change rate of capacitance at 50 
mVrms is  −29.1 ± 0.4 ‰/min , while 100 mVrms yields a change rate 
of −54.6 ± 2.1 ‰/min. The increase in capacitance change rate slows down 
when the voltage goes above 100 mVrms, which could be caused by possible 
adverse effect that electric field may have on the activities or adhesion of serum 
antibodies. Nevertheless, the increase of capacitance change rate with voltage 
amplitude serves to corroborate the contribution of ACEK effect in this 
capacitive assay. The results in Figure 6.6a also let us set 100 mVrms as the 
optimal operating voltage of serum antibody detection. Additionally, the control 
solution consistently exhibited low capacitance change rates throughout the 
voltage range, indicating that the high response from positive sample is not 




























































Figure 6.6 Capacitance change rates of JD positive serum sample and control 
buffer (0.1X PBS) when they are tested at (a) 100 kHz AC signals of various 
voltage amplitudes, (b) 100 mVrms AC signals at different frequencies. Each 
data point shows the average of three tests. Error bar indicates the standard 
deviation. 
 
Secondly, as DEP force is frequency dependent, there should exist a 
specific frequency at which the target macromolecules will experience maximal 
attraction force to the electrodes (i.e. the strongest positive DEP). The 
accompanying ACET flows may add to the particle movement caused by DEP, 
but will not affect its frequency properties, since ACET effect is independent of 
AC frequency until a certain level [198, 199]. This time, binding experiments of 
JD positive antibodies are conducted at different frequencies at a fixed 
amplitude of 100 mVrms.  
The capacitance change rates at different frequencies (ranging from 5 kHz 
to 5 MHz) are plotted in Figure 6.6b, which demonstrate a strong frequency 
dependency. The change rate is largest between 100 kHz and 300 kHz, and 
quickly dropped when AC frequency is deviated from this frequency range. The 
bell-shaped frequency dependence clearly indicates DEP characteristics. 
When AC frequency is outside the optimal range, the capacitance change rates 
are still much higher than those of control sample (in contrast to the results of 
5 mVrms assay), which could be attributed to ACET microflows.  
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6.3.4 Detection results of serum samples 
6.3.4.1 Johne’s disease  
As described before, a total of twenty JD serum samples are tested using 
SAW electrodes: ten positive samples and ten negative samples. An AC signal 
of 100 mVrms, 100 kHz is employed as the measuring signal for two minutes. 
The corresponding capacitance change rates are calculated and plotted in 
Figure 6.7, which demonstrating a clear differentiation between capacitance 




Figure 6.7 Detection results of Johne’s disease serum samples. 
 
Moreover, the repeatability test is also conducted by measuring one positive 
serum sample on five different sensor electrodes, with results shown in Figure 
7.2. The calculated coefficient of variation (CV) [200] is only 12.7%, 





Figure 6.8 Repeatability test with JD positive sample. Same positive sample is 
tested five times on five different SAW electrodes. 
 
6.3.4.2 Human and Bovine tuberculosis 
11 Human TB serum samples (6 positive and 5 negative) and 10 Bovine 
TB serum samples (5 positive and five negative) are tested using SAW 
electrodes. The experimental procedure is described as follows: 10 μL of 
hTB/bTB specific antigens are coated on cleaned SAW electrodes for overnight 
(16hrs) under room temperature, then the functionalized electrodes are washed 
with 0.1xPBST for three times and blocked with 0.1x buffer B for 30 minutes. 
Both hTB and bTB serum samples are diluted in 0.1x PBS with a volume ratio 
of 1:20 prior to loading.  
Before testing the serum batch, the frequency of the applied AC signal is 
optimized by testing a positive hTB serum sample with 100 mVrms AC signals 
at 10, 20, 50, 100, 200 kHz and 1 MHz on different electrodes Except for 100 
kHz, responses from five of the AC frequencies average around ~10.0 ‰ 
change in Cint, while 100 kHz AC signal yields ~ 50.0 ‰ change. As a result, 
an AC signal of 100 mVrms at 100 kHz is applied to be the optimal test 
frequency for TB serum samples. Testing time is one minute for each sample. 
The results of TB detection using capacitive sensing are shown and 



















as the control sample.  
 
 
Figure 6.9 Capacitive sensing vs. ELISA of human TB (hTB) positive and 





Figure 6.10 Capacitive sensing vs. ELISA of bovine TB (bTB) positive and 
negative serum samples from badgers. (P: positive samples, N: negative 
samples; C: control buffer) 
 
As could be seen, disease-positive sera always exhibit large responses 
than disease-negative samples, which is consistent with the fact that disease-
positive serum samples have higher concentrations of disease-specific 
antibody. Also, two types of control experiments are conducted. One, as shown 
in Figures 6.9 and 6.10, uses functionalized electrodes with serum-free buffer. 
Another control experiment (data not shown in the figure to avoid confusion) 
uses un-functionalized electrodes (blocked but without antigen) with positive 
 
 
    Capacitive sensing of hTb      ELISA of hTb                
Capacitive sensing of hTb      ELISA of hTb             
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serum samples. The control experiment shows little changes in Cint, which 
is −2.4 ± 1.1 ‰/min, demonstrating the specificity.  
The fact that bovine TB shows negative changes in capacitance while 
human TB shows positive changes could be explained by referring to Chapter 
3. Suppose bounded hTB antibodies have larger separation from each other 
than that of bound bTB antibodies, and then consequently hTB samples would 
lead to an increase of interfacial capacitance after binding, while bTB samples 
would lead to decreased interfacial capacitance after binding.   
Again, to demonstrate the repeatability of the ACEK-based capacitive 
sensing method, one bTB-positive and one bTB-negative serum sample are 
tested on five different SAW electrodes for a total of ten chips. The test results 
and their respective CVs are shown in Table 6.4. The CV for bTB-positive serum 
is calculated to be 9.2%, showing good repeatability. The CV for bTB-negative 
serum is expected to be larger since the response of negative sample is 
relatively small.  
 
Table 6.4 Repeatability test with bTB samples. Each sample is tested five 
times on five different chips. 
Samples 
Capacitance change rate (‰/min) 
Chip 1 Chip 2 Chip 3 Chip 4 Chip 5 STD CV 
bTB-
positive 
-21.5 -29.5 -27.1 -25.9 -27.0 2.4 9.2% 
bTB-
negative 
-2.4 -3.4 -2.0 -1.7 -3.1 0.6 23.3% 
6.4 Influenza A virus Detection 
   Influenza (Flu) is a contagious respiratory infection caused by a variety of 
flu viruses [201]. There are three types of flu viruses: A, B and C [202]. Type A 
flu virus is the most commonly cause of large flu epidemics, it is capable of 
infecting both humans and animals. Compared with type A, type B can only 
affect humans and it is usually less common and severe. Type C can also cause 
flu symptoms but are much less severe compared with flu A and B. In this work, 
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we focus on the detection of Influenza A virus using our capacitive affinity 
sensor. 
6.4.1 Sample preparation 
Influenza A antibody: mouse monoclonal Influenza A antibody (H1NI, 
isotype: IgG2a) is provided by Meridian Bioscience, Inc. In this work, antibody 
is diluted in 0.1x PBS.  
Influenza A virus (clean standard): purified and inactivated Influenza A 
antigen strain (H3N2) cultured in embryonated chicken eggs are provided by 
Meridian Bioscience, Inc. In this work, virus samples (diluted in 0.1x PBST) of 
three concentrations are tested: 10, 100 and 1000 ng/mL. Tween 20 is added 
to help to release the available binding sites of the virus. 
Influenza A virus (nasal swab): clinical nasal swab samples containing 
Influenza A viral particles are provided by Meridian Bioscience, Inc. In this work, 
clinical sawb samples are diluted in 0.1x PBST.  
6.4.2 Specificity 
   Influenza A (Flu A) detection is performed using 2μm gold electrodes. The 
experimental procedure is described as follows: 10 μL of antibody at 
concentration of 200 ng/mL (diluted in 0.1x PBS) is first added on cleaned 
electrodes as probe molecule, and the electrodes are then kept in a humidor 
for six hours for surface functionalization under room temperature. After surface 
functionalization, the electrodes are washed with 0.1x PBST for three times and 
then blocked with 0.1x buffer B for 45 minutes. The electrodes are then 
connected to the impedance analyzer and Influenza A virus samples will be 
introduced to the surface. Samples are tested at concentrations from 10 ng/mL 
to 1000 ng/mL (diluted in 0.1x PBST). An AC signal of 10-100 mVrms at 100 
kHz is then continuously applied for 30 seconds and the corresponding 
capacitance change versus time is recorded. 
88 
 
   One of the biggest concerns in Flu A detection is whether the detected 
signal is from a specific biointeraction. In reality, most clinical samples are 
complex, which means both type A and B viruses can exist at the same time. 
As a result, there are chances that cross reactivity might take place and 
interfere with the detection. To verify the specificity of our capacitive affinity 
assay, four different scenarios are designed and tested, as shown in Figure 
6.11:  
1. True positive: Flu A antibody functionalized chips tested with Flu A virus. 
2. Cross reactivity: Flu A antibody functionalized chips tested with Flu B 
virus. 
3. True negative: Flu A antibody functionalized chips tested with buffer. 
4. Non-specific: Unfunctionalized chips tested with Flu A virus.  
 
 
Figure 6.11 Specificity test of Influenza A: four different scenarios. 
 
Figure 6.12 shows the capacitance change rates of the four cases under 
two different voltage levels: 10 mVrms and 100 mVrms. The initial test plan is 
to apply 100 mVrms, yet it is found that the non-specific signal at 100 mVrms 
reaches −0.49 ± 0.16 %/min, which is very close to the specific binding signal 
of true positive ( −0.66 ± 0.11 %/min ). It indicates that the ACEK induced 
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particle and fluid movement might be excessive. To prove our hypothesis, a 
much lower signal, 10 mVrms, is applied and the same test is performed again. 
As expected, non-specific signal at 10 mVrms is reduced to  −0.23 ±
0.05 %/min, while specific binding signal remains at a relatively high level 
(−0.48 ± 0.10 %/min). In addition, it is exciting to see that cross reactivity 
signals stay at low level for both 10 mVrms (−0.06 ± 0.02 %/min) and 100 
mVrms (  −0.23 ± 0.07 %/min ), proving the specificity of the ACEK-based 
capacitive affinity sensing. 
 
 
Figure 6.12 Capacitance change rates for the four scenarios under 10 and 
100 mVrms. Each data point is the average of three repeated tests. Error bar 
indicates standard deviation. 
 
6.4.3 Effect of linker molecules 
So far, for the assays we have described (bovine IgG antibody, JD, TB and 
Influenza A), only passive adsorption has been applied as the surface 
functionalization method. In Chapter 5, we mentioned that using linker 
molecules could possibly facilitate surface functionalization by forming strong 
and uniform probe coating, hence the sensor is expected to show better 
sensitivity and stability.  
In the detection of Influenza A, sensors functionalized with passive 
adsorption are found to show some instable results, especially for high 
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concentration samples. Table 6.5 listed the capacitance change rates of 1000 
ng/mL virus sample from five different sensors. As can be seen, for the same 
sample, the highest response reaches −0.9 %/min, while the lowest response 
is only −0.29 %/min. Moreover, CV is calculated to be 45%, which is obviously 
out of the usable range (normally <15% is required). Therefore, for the purpose 
of improving sensing stability and repeatability, the usage of linker is introduced 
for Influenza A detection. 
 
Table 6.5 Repeatability test with flu A virus. 1000 ng/mL virus sample is tested 
five times on five different chips. 
Samples 
Capacitance change rate (%/min) 
Chip 1 Chip 2 Chip 3 Chip 4 Chip 5 STD CV 
Flu A virus 
(1000 ng/mL) 
-0.47 -0.97 -0.90 -0.42 -0.29 0.28 45% 
 
 As described before, thiol linker molecules have strong affinity towards 
gold electrodes. In this work, thiol linker (3-MPA) is applied on 2μm gold 
electrodes for surface functionalization following the procedure described in 
Chapter 5. After the formation of thiol SAM, antibody is added to the surface for 
two hours in a humidor under room temperature. Blocking and analyte detection 
procedures are the same as described in 6.4.2. An AC signal of 10 mVrms at 
100 kHz is applied as the measuring signal for 30 seconds, with capacitance 






Figure 6.13 Flu A detection results: passive adsorption vs. thiol linker. Each 
data point is the average of five repeated tests. Error bar indicates standard 
deviation. 
 
In Figure 6.13, it is clear that binding responses get much more stable with 
linker functionalized sensors: for example, at 1000 ng/mL, the capacitance 
change rate is −0.61 ± 0.27 %/min for passive adsorption, which is improved 
to −0.83 ± 0.09 %/min  for linker functionalized sensors. It demonstrates 
higher responses while lower instability, which proves the effectiveness of using 
thiol linker molecules. Moreover, the binding sensitivity is also improved from 
−0.21 ± 0.15 %/log (ng/mL) to −0.48 ± 0.10 %/ log(ng/mL) when thiol linker 
is applied for surface functionalization. 
6.4.4 Blocking optimization 
As mentioned in Chapter 5, the purpose of surface blocking is to cover the 
open spaces on the electrodes to minimize non-specific deposition of 
bioparticles. In the detection of Influenza A, various blocking methods are 
adopted. Based on the binding responses from flu A virus samples, their effects 







Table 6.6 Descriptions of various blocking methods and major conclusions. 
Blocking reagent Time Temperature Conclusions 
0.1x buffer B 30 mins RT 
Commonly used blocking plan in 
affinity biosensing. Works fine 
with Influenza A detection. 
0.1x buffer B 45 mins RT 
Slightly better at reducing non-
specific responses. 
0.1x buffer B 1 hr RT 
No clear difference compared 
with 45 mins blocking. 
0.1x buffer B 1 hr 37℃ 
No clear difference compared 
with RT. 
1x buffer B 30 mins RT 
Too strong, specific response is 
reduced a lot. 
1x buffer B 1 hr RT 
Too strong, specific response is 
reduced a lot. 
2 v/v% BSA 30 mins RT 
Too strong, specific response is 
reduced a lot. 
0.2 v/v% BSA 30 mins RT 
Works fine with Influenza A 
detection, but not showing any 
better than 0.1x buffer B. 
 
  From Table 6.7, it is concluded that a 45 minutes blocking with 0.1x buffer B 
under room temperature yields the optimal binding response. It is therefore 
chosen to be the blocking method for influenza A detection. 
6.4.5 Blind test of clinical swab samples 
Twenty clinical swabs samples collected from different patients are provided 
by Meridian Bioscience Inc. The identities of the samples are confirmed by PCR 
(Cepheid Xpert [203]), yet they are not informed before being tested by the 
ACEK-based capacitive affinity sensor. Prior to detection, these swab samples 
are diluted 1:1000 v/v% in 0.1x PBST.  
   Table 6.7 listed and compared the results obtained by the capacitive affinity 
sensing method with the PCR confirmed results. Out of the twenty samples, 
only four of them are detected wrongly (in red) and one of them is called to be 
undetermined by both methods (in orange). The overall success rate reaches 
93 
 
79% (15/19), which is very promising.   
 






PCR results provide by 
Meridian Bioscience Inc. 
No.1 1.57 N N 
No.2 -1.59 P N 
No.3 -2.14 P P 
No.4 0.43 N P 
No.5 -0.17 N N 
No.6 0.05 N N 
No.7 -1.83 P P 
No.8 3.78 N N 
No.9 -3.71 P P 
No.10 -0.50 ? P 
No.11 0.76 N N 
No.12 -3.03 P P 
No.13 -1.39 P N 
No.14 0.53 N N 
No.15 -0.56 ? ? 
No.16 1.01 N N 
No.17 -0.86 P P 
No.18 -3.44 P P 
No.19 -0.96 P P 
No.20 -1.24 P P 
 
6.5 Small molecule detection 
As the name implies, small molecule refers to biomolecules which sizes are 
on the order of nm (low molecular weight, < 900 Da). For example, the 
molecular weight of BPA is only 228 Da, while for anti-bovine IgG antibody, the 
molecular weight is 150 kDa. In this work, two types of small molecules with 




Bisphenol A (BPA) is an industrial chemical used as an intermediate to make 
polycarbonate plastic, epoxy resins and many other specialty products [204]. It 
can be found in many of daily used items including water bottles, food 
containers, and paper products for decades [205]. Yet recent studies have 
found the exposure of BPA could probably cause adverse health issues to 
humans [185, 206]. It is reported that BPA is an endocrine-disrupting chemical 
and its estrogenic activity could affect different organs [207]. Thus detection of 
BPA level within the environment as well as human serum is of crucial 
importance. Current BPA detection methods include high performance liquid 
chromatography (HPLC) [208, 209] and gas chromatography-mass 
spectrometry (GC-MS) [210, 211]. While good detection limits were reported, 
e.g. 0.04 ng/mL by HPLC, these methods require the use of sophisticated and 
costly instruments by skilled personnel, and yet the operation is complex and 
time-consuming. Therefore, a simple, affordable and label-free method to 
monitor BPA level in environmental samples is highly desired. 
Progesterone is a hormone produced mainly in the ovaries. In pregnancy, 
after an ovum is released, progesterone helps make the uterus ready for 
implantation of a fertilized ovum and prepares the uterus for pregnancy and the 
breasts for milk production [212]. In dairy industry, pregnancy test is an 
important management measure to keep cattle producing milk with minimized 
open (non-lactating) period [213, 214]. Currently, pregnancy tests are 
conducted by either transrectal palpation or immunoassay in diagnostic 
laboratory. Previous studies indicated that palpation in early gestation 
increased risk of embryonic mortality [215]. Current format of immunoassay for 
progesterone is enzyme-linked immunosorbent assay (ELISA), which requires 
the use of laboratory equipment and several hours of labor. Comparing with the 
current format, ACEK-based capacitive affinity sensing is expected to obtain 




6.5.1 Sample preparation 
6.5.1.1 Bisphenol A 
The preparation of BPA specific aptamer and spiked BPA sample is 
described as follows: 
    BPA specific aptamer: The specific aptamer with 5’ thiol modifier C6 
SH is synthesized by Sangon Biotech (Shanghai) Co., Ltd. The 
sequence of the aptamer (5’ to 3’) is 5’-CCG GTG GGT GGT CAG GTG 
GGA TAG CGT TCC GCG TAT GGC CCA GCG CAT CAC GGG TTC 
GCA CCA-3’. In this work, aptamer is diluted in 0.1x PBS.   
    Spiked BPA sample: 4, 4’-Isopropylidenediphenol (BPA) is 
purchased from Fisher Scientific, Pittsburgh, PA. Dimethyl Sulfoxide 
(DMSO), ≥99.7% is also purchased from Fisher Scientific, which is 
used as the solvent for BPA. 0.1x PBS is used for the dilution of BPA. 
    Triton X-100 stock solution is purchased from Alfa Aesar, Ward Hill, 
MA, which is used as the blocking buffer. 
6.5.1.2 Progesterone 
The preparation of anti-PG antibody and spiked PG sample is described as 
follows: 
    Anti-progesterone polyclonal antibody (Fisher Scientific, PA175366), 
Host Species: Sheep Species Reactivity: Chemical Immunogen: 
Progesterone (11)-BSA 100 µL; Unlabeled 100 µL). In this work, purified 
anti-progesterone polyclonal antibody is diluted in 0.1x PBS. 
    Spiked progesterone: Acros Organics (thru Thermo Fisher Scientific 
[Pittsburg, PA] #225650050), stock 10 mg/mL in DMSO. In this work, 
progesterone is diluted in 0.1x PBS. 
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6.5.2 Detection of BPA 
The detection of BPA is performed using both SAW and gold electrodes, 
with procedures described as follows: cleaned electrodes are functionalized 
with thiol modified aptamer (0.1 μM, diluted in 0.1x PBS) for two hours in a 
humidor under room temperature, then the electrodes are washed with 0.1x 
PBST for three times and blocked with 0.1 v/v% Triton X-100 for 30 minutes. 
0.1 v/v% Triton X-100 is prepared by adding 10 μL of Triton X-100 stock solution 
into 10 mL of purified water. BPA (11.3 mg) is dissolved into 5 mL DMSO to 
make 10 mM BPA solution, which is then serial diluted to reach concentrations 
from 1 fM to 1 pM using 0.1x PBS. The electrodes are then connected to the 
impedance analyzer and BPA samples will be introduced to the surface for 
testing. 
For BPA testing, the test frequency is chosen to be 20 kHz instead of 100 
kHz because the whole electrolyte/electrode system is more capacitively 
dominant around this specific frequency. Taking SAW electrode as an example, 
actual impedance measurement at 20 kHz showed a 𝑅𝑓  of 1879 Ω and a 




where 𝑙 = 𝜋𝑙/2 is the half circle over the electrode gap of 1.1 𝜇𝑚, and A is the 
electrode area, 628×150×0.7 𝜇𝑚2 for the whole array; 𝜎=0.15 S/m is the fluid 
conductivity. 𝑅𝑓 is estimated to be 1747 Ω for the electrode array. Meanwhile, 
according to 𝐶𝑖𝑛𝑡 =
𝜀𝐴
𝑑
, where  is the permittivity of the fluid and biomolecule 
( = 0 𝑟, with 0 being the permittivity of free space and 𝑟 being the relative 
permittivity of fluid and biomolecule), A is the area (628×150×1.4 𝜇𝑚2 ) and 𝑑 
is the thickness of the double layer plus the immobilized biomolecules (around 
10 nm), 𝐶𝑖𝑛𝑡 is estimated to be around 9.1 nF. Since both of the theoretical 
values are very close to the measured value, a simplified 𝐶𝑖𝑛𝑡 - 𝑅𝑓  serial 
connected equivalent circuit can adequately account for the impedance of the 




First of all, as a proof of concept, different concentrations of BPA samples 
are tested under 500 mVrms AC signal at 20 kHz for a total of 20 seconds using 
SAW electrodes. Figure 6.14 presents how normalized capacitance changes 
with time for various sample concentrations. The curve of buffer (black line with 
square) remained flat throughout the detection period, showing no occurrence 
of biointeraction. For BPA samples ranging from 1 to 1000 fM, the capacitance 
change rates become larger with increasing concentrations, manifesting the 
increasing level of specific BPA binding. Meanwhile, the curve of non-specific 
(100 fM BPA, without aptamer) goes down a little, indicating the existence of 
certain level of non-specific binding (red line with circle).  
Also, according to Figure 6.14, there are signs of BPA depletion for lower 
concentrations after the first 10 seconds of binding, as the curves are gradually 
becoming flatter. To demonstrate the binding event with time more accurately, 
Table 6.8 lists the change rates at two different time periods: 0-10 seconds and 
10-20 seconds. Except for 1000 fM, the change rate in the first 10-second 
period is always larger than that in the second 10-second period, as the 
depletion of target molecules starts to show as time goes by. In the first 10 
seconds, the capacitance change rate of 10 fM BPA quickly reaches 
−1.73%/min, which is higher than both of the non-specific (−1.23 %/min) and 
buffer control (-0.02 %/min), demonstrating a successful detection.  
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Figure 6.14 Characteristic changes of interfacial capacitance with time when 
different samples are tested. Binding reactions with 1, 10, 100 and 1000 fM 
BPA are shown here. Buffer (blank without BPA) and non-specific (1pM BPA 
sample tested on dummy electrodes) are shown as controls. 
 
Table 6.8 Capacitance change rates within two different time periods. 
dC/dt (%/min) 0-10s 10-20s 
0.1x PBS -0.02 0.23 
Non-specific -1.23 -0.1 
1 fM (0.28 fg/mL) -0.68 -0.34 
10 fM (2.8 fg/mL) -1.73 -0.08 
100 fM (28 fg/mL) -1.71 -1.1 
1 pM (280 fg/mL) -2.74 -1.12 
 
6.5.2.2 Study of ACET effect 
As discussed earlier, the size of small molecules are much tinier compared 
with antibodies. From Chapter 4, we see that the relative importance of DEP 
and ACET forces will shift in favor of ACET effect with smaller molecules, as 
DEP force is dependent on the particle volume while ACET force is not. As a 
result, DEP enrichment will be much weaker for BPA than for antibodies. So the 
use of ACET effect should be more important to small molecule detection. BPA 
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samples from 1 to 100 fM are tested on both SAW and 5μm gold electrodes as 
a comparison. The applied electric field strength is very similar, which is 50 
mV/μm on SAW electrodes and 46 mV/μm on 5μm electrodes. 
Figure 6.15 shows the outputs from both SAW and 5μm gold electrodes. It 
can be seen that the rate of decrease in capacitance steadily gets larger with 
more concentrated samples on both electrodes. The responses from both 
electrodes exhibited a logarithmic dependence on BPA concentration ranging 
from 1 to 100 fM.  As expected, much larger capacitance change is seen from 
5μm gold electrodes, which is clearly the result of stronger ACET convection. 
While for SAW electrodes, although the electric field strength is slightly larger, 
the response is less obvious than that from 5μm gold electrodes. The detection 
sensitivity of 5μm gold electrodes is calculated to be −0.40 ± 0.08 %/log (fM), 




Figure 6.15 BPA detection results on both electrodes. Buffer tests are 0.1x 
PBS on functionalized electrodes; non-specific tests are 1-100 fM BPA on 
dummy electrodes; specific tests use 1-100 fM BPA samples on functionalized 
electrodes. Each data point is the average of three repeated tests and the 




6.5.2.3 Determination of LOD 
From Figure 6.15, we could also determine the limit of detection (LOD) of 
the two electrodes. Baseline responses are obtained by measuring buffer, 
which are 0.01 ± 0.02 %/min on 5μm gold electrodes and 0.16 ± 0.15 %/min 
on SAW electrodes. Besides, responses from non-specific binding are minimal 
on both electrodes. 100 fM BPA caused a change rate of −0.10 ± 0.02 %/min 
for 5μm electrodes, and 0.01 ± 0.11 %/min for SAW electrodes, showing good 
specificity. In comparison, 5μm electrode produces a change rate of −0.50 ±
0.11 %/min for 10 fM BPA, which can easily be distinguished from the baseline. 
SAW electrodes yield a change rate of −0.36 ± 0.07 %/min for 100 fM BPA, 
which could be also be differentiated. Therefore, LOD is determined to be 10 
fM for 5μm electrode and 100 fM for SAW electrodes. 
6.5.3 Preliminary detection of PG 
Similar to BPA, the detection of progesterone is also categorized as small 
molecule detection. Progesterone is very small in size and weight, with a 
molecular weight of only 315 Da. Some preliminary experiments are performed 
in this work using SAW electrodes. 
The experimental procedure is described as follows: cleaned electrodes are 
functionalized with anti-PG polyclonal antibody (0.15 μM, diluted in 0.1x PBS) 
for two hours in a humidor under room temperature, then the electrodes are 
washed with 0.1x PBST for three times and blocked with 0.1x buffer B for 30 
minutes. The electrodes are then connected to the impedance analyzer and PG 
samples will be loaded for test. PG sample is diluted in 0.1x PBS to get three 
different concentrations of progesterone: 0.5ng, 1ng and 5 ng/mL. 
An AC signal of 100 mVrms at 100 kHz is applied continuously for one 
minute as the measuring signal. Preliminary results with passive adsorption as 
surface functionalization method do not show an adequate differentiation, thus 
in order to achieve better performance, we also introduce APTES-treated SAW 
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electrodes to improve its sensitivity. The procedure of APTEPS treatment has 
been described in Chapter 5. 
Figure 6.16 shows the preliminary results of spiked PG sample detection. 
Three different concentrations of PG are tested consecutively on the same chip, 
from low to high. 0 ng/mL means control buffer (0.1x PBS). As could be seen, 
binding begins to saturate at 5 ng/mL, since the available binding sites are 
limited, capacitance would not change much after the binding starts to saturate. 
Furthermore, as expected, chips treated with APTES showed higher 
capacitance change compared with bare chips. This could be explained by the 
fact that APTES increases the surface availability, i.e. more binding sites are 
provided. Although the limit of detection is not increased since the background 
also goes higher, the sensitivity is indeed increased with APTES-treated chips. 
For APTES-treated chips, sensitivity is about 0.6 %/ (ng/mL), while for bare 
chips, sensitivity is only around 0.2 %/ (ng/mL). The limit of detection is 
determined to be 1 ng/mL (3.2 nM) for spiked progesterone detection.  
 
 
Figure 6.16 Detection results of progesterone binding. Different change rates 
indicate different binding levels. Each test is repeated three times. Error bar 





Chapter 7. Conclusions and Future 
Work 
7.1 Summary 
This work presents an ACEK-based capacitive affinity sensing method that 
holds high promise for POC disease diagnosis. The detection is realized 
through a capacitive sensing technique with a microelectrode array.  
The capacitive affinity sensing technique has two major functions: realizing 
the study of nanoscale surface structure and deposition; and carrying out the 
detection of specific surface biomolecular interactions. In this work, the first 
function is used for surface quality controlling of sensor electrodes, while the 
second function is applied to detect specific biomolecular interaction, such as 
antigen-antibody binding. 
The capacitive assay presented in this work can achieve ACEK enrichment 
of biomolecules and label-free detection of deposition on the microelectrode 
surface simultaneously. The experiments proved that DEP and ACET effect 
could speed up the biointeraction process to achieve rapid and sensitive 
detection. Compared with conventional methods, the detection time has been 
greatly reduced from hours to minutes. 
We also carefully choose our electrode design and detection protocol, so 
that at the AC enrichment frequency, the detection cell can be represented with 
a simplified resistor-capacitor serial connection (fluid resistance in series with 
electrode/fluid interfacial capacitance). Because the effect of sample matrix 
mostly shows up in its resistive component (e.g. charge transfer resistance), 
the detection method and device combined is relatively unsusceptible to the 
interference from the background solution. As a result, this method needs little 
pretreatment of the sample (sample pre-treatment requires only volume dilution 
of serum samples with physiological buffer), and does not require a washing 
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step after binding, which is a major advantage over traditional impedimetric 
biosensors.  
In summary, the ACEK-based capacitive biosensor has a shorter assay time, 
reduced reagent and device cost, simpler device design and operation than 
conventional diagnostic system. The potential of this sensing technique for 
rapid disease detection might greatly facilitate the battle against the epidemic 
of infectious diseases in the future. 
 
7.2 Future Work  
7.2.1 Further improvement of feasibility 
To build a fully qualified sensing technology for POC diagnosis in real world, 
the feasibility of the ACEK-based capacitive sensor needs further improvement. 
Compared to electrical signal readout, biological related issues pose more 
uncertainties to sensor performance. Surface functionalization is always the 
most crucial step in affinity biosensing. In this work, only the effect of 3-MPA is 
studied on gold electrodes. Further effort would be focused on the study of 
various thiol linker molecules, such as 11-mercaptoundecanioc acid (11-MUA). 
Compared with 3-MPA, 11-MUA has longer chains, which is expected to 
improve the stability of surface functionalization.  
Moreover, the size of the probe molecules could also affect the detected 
signal. For example, in progesterone detection, the size of current probe 
antibody is much larger than the size of progesterone molecule. The huge size 
of probe brings down the detection sensitivity, as the change of capacitance 
due to progesterone binding is less notable. Therefore, finding more proper 




7.2.2 Multiplexed assay with high specificity 
Multiplexed assay, as opposed to single detection, refers to the detection of 
multiple analyte samples simultaneously. It is very useful in real life diagnosis, 
as sometimes it is needed to deal with hundreds or thousands of samples within 
a short time period. To achieve multiplexed detection, IC integration is needed 
to combine several sensors to a single chip, while each sensor should have its 
own independent signal source to avoid interference.  
7.2.3 Handheld device  
The current measurement device is a clumsy benchtop instrument. A 
desired prototype for realizing POC diagnosis would be a light, portable and 
robust handheld device, as conceptually shown in Figure 7.1. Detection results 
could be easily displayed on the screen and can be transferred to a smart phone 
if available. 
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